<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Inorg Chem</journal-id><journal-id journal-id-type="iso-abbrev">Inorg Chem</journal-id><journal-id journal-id-type="publisher-id">ic</journal-id><journal-id journal-id-type="coden">inocaj</journal-id><journal-title-group><journal-title>Inorganic Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0020-1669</issn><issn pub-type="epub">1520-510X</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40315445</article-id><article-id pub-id-type="pmc">PMC12093383</article-id>
<article-id pub-id-type="doi">10.1021/acs.inorgchem.5c00896</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Protoporphyrin IX-Derived Ruthenium(II) Complexes
for Photodynamic Therapy in Gastric Cancer Cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Restrepo-Acevedo</surname><given-names>Andr&#x000e9;s</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Murillo</surname><given-names>Mar&#x000ed;a Isabel</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Orvain</surname><given-names>Christophe</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes-4" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Thibaudeau</surname><given-names>Chlo&#x000e9;</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Recberlik</surname><given-names>Sevda</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes-4" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Verget</surname><given-names>Lucas</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>G&#x000f3;mez Vidales</surname><given-names>Virginia</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath8"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4315-3851</contrib-id><name><surname>Gaiddon</surname><given-names>Christian</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes-5" ref-type="notes">&#x022a5;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath9"><name><surname>Mellitzer</surname><given-names>Georg</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes-4" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath10"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5679-2081</contrib-id><name><surname>Le Lagadec</surname><given-names>Ronan</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label><institution>Universidad
Nacional Autonoma de M&#x000e9;xico, Instituto de Qu&#x000ed;mica UNAM</institution>, Circuito Exterior s/n Ciudad Universitaria, 04510 Ciudad de M&#x000e9;xico, <country>Mexico</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Inserm
UMR_S U1113; IRFAC</institution>, 3 Avenue Moli&#x000e8;re, 67200 Strasbourg, <country>France</country></aff><aff id="aff3"><label>&#x000a7;</label>Facult&#x000e9;
de Chimie, <institution>Sorbonne Universit&#x000e9;</institution>, 4 place Jussieu, 75005 Paris, <country>France</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>mellitzer@unistra.fr</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>ronan@unam.mx</email>.</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>05</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>19</day><month>05</month><year>2025</year></pub-date><volume>64</volume><issue>19</issue><fpage>9684</fpage><lpage>9702</lpage><history><date date-type="received"><day>25</day><month>02</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>04</month><year>2025</year></date><date date-type="rev-recd"><day>22</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0015" id="ab-tgr1"/></p><p>In recent years,
photodynamic therapy (PDT) has emerged as a promising
alternative to classical chemotherapy for treating cancer. PDT is
based on a nontoxic prodrug called photosensitizer (PS) activated
by light at the desired location. Upon irradiation, the PS reacts
with the oxygen present in the tumor, producing cytotoxic reactive
oxygen species (ROS). Compounds with highly conjugated &#x003c0;-bond
systems, such as porphyrins and chlorins, have proven to be excellent
light scavengers, and introducing a metal atom in their structure
improved the generation of ROS. In this work, a series of tetrapyrrole-ruthenium(II)
complexes derived from protoporphyrin IX and the commercial drug verteporfin
were designed as photosensitizers for PDT. The complexes were almost
nontoxic on human gastric cancer cells under dark conditions, revealing
remarkable cytotoxicity upon irradiation with light. The ruthenium
atom in the central cavity of the chlorin ligand allowed combined
mechanisms in photodynamic therapy, as both singlet oxygen and superoxide
radicals were detected. Additionally, one complex produced large amounts
of singlet oxygen under hypoxic conditions. Biological assays demonstrated
that the ruthenium derivatives caused cell death through a caspase
3 mediated apoptotic pathway and <italic>via</italic> CHOP, an endoplasmic
reticulum stress-inducible transcription factor involved in apoptosis
and growth arrest.</p></abstract><abstract abstract-type="short"><p>Tetrapyrrole-ruthenium(II)
compounds were designed as photosensitizers
for PDT. The complexes exhibited low toxicity in the dark on human
gastric cancer cells and remarkable cytotoxicity upon irradiation
with light. Both singlet oxygen and superoxide radicals can be produced,
even at low oxygen concentrations. Cell death is induced <italic>via</italic> a caspase 3 mediated apoptotic pathway and <italic>via</italic> CHOP,
an endoplasmic reticulum stress transcription factor, potentially
making the complexes less vulnerable to drug-resistance mechanisms.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Consejo Nacional de Humanidades, Ciencias y Tecnolog&#x000c3;&#x000ad;as</institution><institution-id institution-id-type="doi">10.13039/501100003141</institution-id></institution-wrap></funding-source><award-id>996154</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Sorbonne Universit&#x000c3;&#x000a9;</institution><institution-id institution-id-type="doi">10.13039/501100019125</institution-id></institution-wrap></funding-source><award-id>279063</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Direcci&#x000c3;&#x000b3;n General de Asuntos del Personal Acad&#x000c3;&#x000a9;mico, Universidad Nacional Aut&#x000c3;&#x000b3;noma de M&#x000c3;&#x000a9;xico</institution><institution-id institution-id-type="doi">10.13039/501100006087</institution-id></institution-wrap></funding-source><award-id>IN-211522</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Direcci&#x000c3;&#x000b3;n General de Asuntos del Personal Acad&#x000c3;&#x000a9;mico, Universidad Nacional Aut&#x000c3;&#x000b3;noma de M&#x000c3;&#x000a9;xico</institution><institution-id institution-id-type="doi">10.13039/501100006087</institution-id></institution-wrap></funding-source><award-id>IN-207725</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Consejo Nacional de Humanidades, Ciencias y Tecnolog&#x000c3;&#x000ad;as</institution><institution-id institution-id-type="doi">10.13039/501100003141</institution-id></institution-wrap></funding-source><award-id>A1-S-15068</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ic5c00896</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ic5c00896</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Photodynamic therapy (PDT) is an approved
anticancer strategy with
high temporal selectivity, which presents several advantages over
conventional radiotherapy and chemotherapy, such as few side effects
and as a noninvasive therapy.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Platinum-based complexes,
such as cisplatin, carboplatin, and oxaliplatin, have become the most
used metal-based drugs worldwide for cancer treatment by chemotherapy.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> However, although these anticancer drugs are very effective, their
efficiency is limited due to the high incidence of resistance mechanisms.
In addition, they lack selectivity toward cancer cells, which leads
to numerous undesirable side effects such as nephrotoxicity, neurotoxicity,
and ototoxicity, among others.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> As an alternative to
classical chemotherapy, PDT emerged as a promising strategy for treating
cancer. Treatments by PDT are based on a nontoxic prodrug called a
photosensitizer (PS) that can be activated by light at the desired
location.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup> Upon photoactivation, the PS releases the
energy needed to react with the oxygen present in the tumor, producing
reactive oxygen species (ROS) such as singlet oxygen (<sup>1</sup>O<sub>2</sub>), superoxide radical (O<sub>2</sub><sup>&#x02022;<bold>&#x02013;</bold></sup>), hydroxyl radical (<sup>&#x02022;</sup>OH)
and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Such species are
spatially and temporally confined to the irradiated region, thus targeting
malignant tissues without attacking healthy ones.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Two types of PDT have been described. In type II reaction,
high amounts of highly toxic singlet oxygen are produced, causing
oxidative damage in cells. In type I reaction, the PS in singlet or
triplet excited state can react directly with a biological substrate
and undergo hydrogen atom abstraction or electron transfer reactions,
giving rise to highly reactive free radicals and radical ions, which
can generate different ROS and cause cell death.<sup><xref ref-type="bibr" rid="ref11">11</xref>&#x02212;<xref ref-type="bibr" rid="ref13">13</xref></sup></p><p>Ideally,
a PS should preferentially (i) accumulate in tumors, (ii)
display no toxicity in the dark, and (iii) be rapidly eliminated from
the body.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> The PS should also present a high quantum
yield of ROS production, a high molar extinction coefficient, and
molar absorbance. Absorbance in the red spectral regions (600&#x02013;800
nm) is desired for deep-seated tumors, <italic>i.e.</italic>, in cancers
of the stomach, bladder, pancreas, esophageal or glioblastoma multiforme,
among others.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> Compounds with highly conjugated
&#x003c0;-bond systems, such as porphyrins and chlorins, are excellent
light scavengers and are, therefore, ideal PS for PDT.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Additionally, such tetrapyrrole structures can
host a wide variety of metal ions. For example, it has been observed
that metaloporphyrins with paramagnetic metal ions such as Cu(II)
or Co(II) present low ROS production due to a decrease in the lifetime
of the excited triplet state of the PS. On the contrary, metaloporphyrins
with diamagnetic ions such as Zn(II), Pd(II), In(III), Ru(II), Ir(III),
and Pt(II) present the heavy atom effect with a strong spin&#x02013;orbital
coupling that provides an absorbance lifetime long enough for the
excited triplet state to interact with dioxygen, thus favoring the
generation of ROS and, therefore, increasing the quantum yields.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> For instance, a palladium(II)
metalochlorin complex (padeliporfin, TOOKAD) has been approved in
several EU countries, Israel and Mexico, for use as a PS for the treatment
of localized prostate cancer (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Ruthenium(II) complexes
have generated interest as photosensitizers in PDT due to their favorable
photophysical properties compared to other transition metals, including
broad absorption spectra and long excited state lifetimes. Moreover,
the absorption and emission wavelengths can be precisely tuned through
ligand design. Furthermore, ruthenium(II) complexes frequently exhibit
high chemical and photochemical stability, allowing them to withstand
light without degradation.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> In this respect, TLD1433
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) is the first
ruthenium-based PS that has entered a phase II clinical trial to treat
noninvasive bladder cancer.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Interestingly,
in most of the reports where porphyrins and ruthenium are used, the
metal atom is found in the peripheries of the macrocycle, and only
a few metaloporphyrins with the ruthenium atom in the central cavity
have been described.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> However, many Ru(II) complexes
are poorly soluble in water, which may limit their ability to reach
target tissues. Low water solubility can cause aggregation, reduced
bioavailability, and ineffective cellular uptake. The clinical applications
of these complexes have also been restricted due to their cytotoxicity
in the dark and low ROS generation efficiency.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Compounds
approved or in clinical trials as photosensitizers for
PDT.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0001" id="gr3" position="float"/></fig><p>It is worth mentioning that PDT
is not only used in cancer treatment.
For instance, verteporfin (<bold>VP</bold>, Visudyne) is widely used
for treating macular degeneration.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> However,
the use of <bold>VP</bold> has several disadvantages, such as high
phototoxicity and slow elimination by the body, meaning that the patient
will be photosensitized for more than 48 h after the therapy.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup></p><p>Therefore, inspired by the photoproperties of porphyrins and
chlorins,
a ruthenium(II) ion was introduced in the central cavity of a series
of tetrapyrroles to study their potential use as PS for the treatment
of cancer, focusing on gastric cancer. Gastric cancer (GC) represents
a public health problem due to its high aggressiveness, with a 5-year
survival rate of less than 25% and a median survival of about 11 months.
It represents the fifth leading cause of cancer-related death in the
world, after lung, breast, colon, and liver cancers, with around 769,000
deaths in 2020 (7.7% of all cancers), according to the World Health
Organization (WHO).<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> In terms of incidence,
GC is the fifth most common cancer, with more than one million new
cases diagnosed in 2020 (5.6% of all cancers).<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref32">32</xref></sup> Treatment options are still very limited, and patient management
is mainly based on partial or complete gastrectomy combined with oxaliplatin-based
(oxaliplatin + 5-Fluorouracyl) neoadjuvant and/or adjuvant chemotherapy.
Unfortunately, the efficacy of the treatment is impaired by various
resistance mechanisms,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> notably due to
mutation in p53, which is mutated in up to 70% of GC.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Consequently, there is an urgent need to develop new therapeutic
solutions whose mode of action is independent of p53. In this respect,
ruthenium-based anticancer compounds have been shown to induce cell
death independently of p53, targeting different metabolic pathways
and reducing tumor growth <italic>in vivo</italic>.<sup><xref ref-type="bibr" rid="ref35">35</xref>&#x02212;<xref ref-type="bibr" rid="ref37">37</xref></sup> In addition,
as the gastric cavity is accessible by endoscopy, combining ruthenium
with PDT would be an attractive solution for a localized GC treatment.</p></sec><sec id="sec2"><title>Results
and Discussion</title><sec id="sec2.1"><title>Chemistry</title><sec id="sec2.1.1"><title>Synthesis and Characterization</title><p>The porphyrins <bold>1</bold> and <bold>2</bold> derived from protoporphyrin
IX (<bold>PpIX</bold>) were synthesized by adapting a described procedure
from
commercial <bold>Na</bold><sub><bold>2</bold></sub><bold>PpIX</bold> salt and methanol or benzyl alcohol in an acidic medium (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthesis of Ligands and Numbering Used for NMR Assignation</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0013" id="gr1" position="float"/></fig><p>Porphyrins <bold>1</bold> or <bold>2</bold> were
used to prepare
the chlorins through a Diels&#x02013;Alder reaction, modifying a reported
procedure.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Porphyrin <bold>1</bold> or <bold>2</bold> was refluxed with dimethyl acetylenedicarboxylate (DMAD)
in dry chloroform for 72 h to form mixtures of <bold>3A</bold> and <bold>3B</bold>, or <bold>4A</bold> and <bold>4B</bold> chlorins (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). Isomers <bold>A</bold> and <bold>B</bold> were readily separated by column chromatography
on silica gel and characterized by one-dimensional (1D) and two-dimensional
(2D)-NMR techniques.</p><p>The <bold>1</bold> and <bold>2</bold> porphyrins
and <bold>3A</bold> and <bold>3B</bold> chlorins were used as ligands
to react with
[Ru<sub>3</sub>(CO)<sub>12</sub>] to form the new ruthenium(II) complexes. <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref> summarizes the synthesis
of the ruthenium derivatives. Two strategies were used to synthesize
ruthenium complexes based on chlorins. In the first approach, a mixture
of chlorins <bold>AB</bold> was reacted with [Ru<sub>3</sub>(CO)<sub>12</sub>], followed by chromatographic separation of the resulting
ruthenium complexes. However, the reaction yield was low, and the
separation of the isomers was problematic. Therefore, the second methodology
consisted of starting from the purified <bold>3A</bold> or <bold>3B</bold> isomers. Ruthenium complexes were obtained in 13 and 16% yields
from the isolated isomer, respectively. The <bold>4A</bold> and <bold>4B</bold> ligands were not metalated as they were obtained in very
low quantities. All the new ruthenium(II) derivatives are stable in
air and light in the solid state and solution.</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Synthesis of Ruthenium
Complexes and Numbering Used for NMR Assignation</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0014" id="gr2" position="float"/></fig><p>All the new compounds were characterized by IR, HR-MS, <sup>1</sup>H and <sup>13</sup>C NMR, DEPT-135, HSQC, and HMBC, and their
purity
was confirmed by HPLC (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S1&#x02013;S61</ext-link>). In addition, crystals suitable for single-crystal X-ray diffraction
crystallography were obtained for <bold>Ru-1</bold> and <bold>3B</bold>.</p></sec><sec id="sec2.1.2"><title>Crystallography</title><p><bold>Ru-1</bold> and <bold>3B</bold> crystals were obtained by slow evaporation of a hexane/dichloromethane
solution. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> shows
the ORTEP diagrams of the structures, and crystallographic data are
summarized in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Table S1</ext-link>.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>ORTEP diagrams (<bold>a</bold>) <bold>Ru-1</bold> and (<bold>b</bold>) <bold>3B</bold>.
Thermal ellipsoids are drawn with a 40% probability
level. Hydrogen atoms are omitted for clarity, except for N&#x02013;H
hydrogen atoms.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0002" id="gr4" position="float"/></fig><p>Compound <bold>3B</bold> crystallized
in an orthorhombic system
with space group <italic>Fdd2</italic>, and the structure confirms
the cycloaddition. The bond distance between N&#x02013;H1 and N&#x02013;H2
is 0.737 and 0.701 &#x000c5;, respectively. In addition, it is observed
that the central structure of the chlorin is planar. <bold>Ru-1</bold> complex crystallized with a water molecule (probably from the solvents
used for crystallization) in the <italic>C</italic>2/<italic>c</italic> space group. It has been reported that in similar porphyrin complexes,
water, methanol, and ethanol molecules can weakly bind to the metal
center <italic>trans</italic> to the CO ligand.<sup><xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref42">42</xref></sup> The angle between the H<sub>2</sub>O&#x02013;Ru&#x02013;C(O) atoms
is 179.04&#x000b0;, while the angles between the nitrogen atoms of porphyrin
and ruthenium atom are 173.72 and 173.83&#x000b0;, indicating that the
structure exhibits a slightly distorted octahedral geometry. The bond
distances between Ru-CO and Ru&#x02013;OH<sub>2</sub> are 1.782(5)
and 2.224(4) &#x000c5;, respectively. The bond distances between Ru&#x02013;N1,
Ru&#x02013;N2, Ru&#x02013;N3, and Ru&#x02013;N4 are 2.051, 2.057, 2.050,
and 2.059 &#x000c5;, respectively.</p></sec><sec id="sec2.1.3"><title>Electronic Absorption</title><p>The ultraviolet&#x02013;visible
(UV&#x02013;vis) absorption spectra of the ligands and complexes were
measured in dimethyl sulfoxide (DMSO) at 37 &#x000b0;C at a 1 &#x000d7;
10<sup>&#x02013;5</sup>&#x0202f;M. <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref> shows the spectra for the ligands and complexes,
and electronic absorption data are given in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Table S2</ext-link>.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Absorption spectra of (a) porphyrins and metaloporphyrins and (b)
chlorins and metalochlorins in DMSO, 1 &#x000d7; 10<sup>&#x02013;5</sup>&#x0202f;M at 37 &#x000b0;C.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0003" id="gr5" position="float"/></fig><p>A strong Soret absorption band around 400 nm is observed in all
the UV&#x02013;vis spectra, indicating &#x003c0;&#x02013;&#x003c0;* transitions
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>).<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> For the ligands, four Q bands in the visible
region are attributed to an &#x003c0;-&#x003c0;* electronic transition
(a<sub>1u</sub> &#x02192; e<sub>g</sub>*) arising from the ground state
(S<sub>0</sub>) to the second excited state (S<sub>2</sub>).<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> For the metaloporphyrinoid derivatives, the
bands around 500 to 600 nm are assigned to charge transfer transitions,
&#x003c0;-d&#x003c0; between the tetrapyrrole ring and the metal. In the
complexes, the decrease in the number of Q bands is ascribed to a
change in the symmetry, from D<sub>2</sub>h to D<sub>4</sub>h, due
to the deprotonation and cation formation.<sup><xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref44">44</xref></sup></p></sec><sec id="sec2.1.4"><title>Stability</title><p>The stability of the compounds was evaluated
by UV&#x02013;vis spectroscopy. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S62&#x02013;S70</ext-link> show the absorption spectra of each compound in DMSO for 24 h at
37 &#x000b0;C at a concentration of 1 &#x000d7; 10<sup>&#x02013;5</sup> M.
The stability was also evaluated in PBS containing 0.1% DMSO (1 &#x000d7;
10<sup>&#x02013;5</sup> M) at 37 &#x000b0;C for 8 h. In DMSO, practically
no decomposition of the compounds was observed (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a). However, in PBS/DMSO (0.1%), a slight
decomposition was noted (between 1&#x02013;10%), as seen in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S71&#x02013;S79</ext-link> show the absorption spectra of each
compound in PBS/DMSO (0.1%). However, in the case of compound <bold>Ru-2</bold>, the decomposition was more important (48% in PBS/DMSO),
as observed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figure S73</ext-link>.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Stability assay for <bold>Ru-1</bold> in (a) DMSO and (b) PBS/DMSO
0.1%. Inset: plot of absorbance <italic>vs</italic> time.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0004" id="gr6" position="float"/></fig></sec><sec id="sec2.1.5"><title>Photobleaching</title><p>Degradation of the molecules upon light
irradiation can cause problems in applications such as photodynamic
therapy.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Photodegradation is an oxidative
degradation of a molecule over time into fragments of lower molecular
weight, implicating that the molecule may lose its photodynamic activity
during irradiation.<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup></p><p>The measurement of light
tolerance and stability of each compound was studied by UV&#x02013;vis
spectroscopy at 37 &#x000b0;C at 1 &#x000d7; 10<sup>&#x02013;5</sup> M. The
cell was irradiated with white light, and a spectrum was recorded
every 3 min until a total of 5 measurements (15 min). <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> shows the spectra obtained
during <bold>Ru-1</bold> and <bold>Ru-3B</bold> photobleaching in
pure DMSO (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a) and PBS/DMSO (0.1%) (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b). Spectra for the remaining compounds are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S80&#x02013;S87</ext-link>. In all cases, only a
slight decrease (1&#x02013;5%) in the absorption of the Soret band
(404&#x02013;410 nm) was observed.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Photodegradation of compound <bold>Ru-1</bold> (a, c) and <bold>Ru-3B</bold> (b, d) in DMSO and PBS/DMSO (0.1%)
upon irradiation
with white light (50% intensity of a 12 W lamp). Inset: plot of absorbance <italic>vs</italic> time.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0005" id="gr7" position="float"/></fig></sec><sec id="sec2.1.6"><title>Fluorescence and Singlet
Oxygen Formation Quantum Yield Measurements</title><p>Emission spectra
were measured in DMSO. The free ligands were excited
at 503 nm, while the ruthenium complexes were excited at 573 nm. The
spectra are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S88&#x02013;S93</ext-link>. For the calculation of fluorescence quantum yield, verteporfin
(&#x003a6;<sub>f</sub> = 0.0085) was used as a reference.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> The results are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Table S2</ext-link>. In all metal-free compounds, an intense emission
band at approximately 630&#x02013;670 nm and a small band at approximately
700&#x02013;750 nm were observed, assigned to Q (0&#x02013;0) and Q
(1&#x02013;0) transitions, respectively.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> On the other hand, the new ruthenium(II) complexes showed no emission.
A similar behavior has been observed in palladium(II) and nickel(II)
metaloporphyrins, where the fluorescence was quenched due to electron
or energy transfer.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup></p><p>An indirect
method was used to calculate the singlet oxygen production quantum
yield of all compounds using 1,3-diphenylisobenzofuran (DPBF), which
in the presence of <sup>1</sup>O<sub>2</sub> oxidizes to 1,2-dibenzoylbenzene
(DBB) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>c).
Verteporfin was selected as a reference (&#x003a6;<sub>&#x00394;</sub> = 0.77 in DMSO).<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> The spectral change
of the absorbance band at 214 nm of the DPBF scavenger was monitored
to determine the singlet oxygen generation. Eleven measurements were
made in a spectrophotometer, one measurement every 6 s after irradiating
the samples with white light, for a total of 60 s. <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>d summarizes the data obtained.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Absorption
changes during the determination of singlet oxygen quantum
yield of <bold>Ru-1</bold> (a) and <bold>3B</bold> (b) using DPBF
as singlet oxygen trapping in DMSO equilibrated with air (inset: plot
of absorbance at 214 nm <italic>vs</italic> irradiation time). (c)
Reaction between DPBF and photosensitizer in the presence of light
and oxygen. (d) Percentage singlet oxygen formation quantum yield
relative to verteporfin (&#x003a6;<sub>&#x00394;</sub> = 0.77<sup><xref ref-type="bibr" rid="ref46">46</xref></sup>). [PS] = 7 &#x000d7; 10<sup>&#x02013;6</sup> M;
[DPBF] = 2 &#x000d7; 10<sup>&#x02013;5</sup> M, <italic>N</italic> = 3.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0006" id="gr8" position="float"/></fig><p>In all cases, the absorbance of DPBF at 214 nm
decreased in the
presence of the compounds, confirming the generation of singlet oxygen.
All the compounds, but <bold>Ru-3A</bold> and <bold>Ru-3B</bold>,
were highly efficient in generating singlet oxygen, with quantum yields
between 30 and 50%. Interestingly, for <bold>Ru-3A</bold> and <bold>Ru-3B</bold>, the singlet oxygen quantum yields were much lower (15%
and 11%, respectively) than for the corresponding free ligands (<bold>3A</bold> and <bold>3B</bold>) and the other ruthenium complexes
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>d).</p></sec><sec id="sec2.1.7"><title>Determination
of ROS Production</title><p>Since singlet oxygen
has a very short half-life, a spin trap and detection of the generated
radical by electron paramagnetic resonance (EPR) were used as an indirect
method to monitor its formation. The spin trap of choice was 2,2,6,6-tetramethylpiperidine
(TEMP), as it can readily be converted into the stable radical 2,2,6,6-tetramethyl-1-piperidinyloxy
(TEMPO) in the presence of singlet oxygen. The formation of TEMPO
was monitored by continuous white light irradiation of the PS <italic>in situ</italic> for 15 min. As seen in <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>a&#x02013;d, the characteristic triplet signal
(<italic>g</italic> = 2.0063 and hfcc = 1.63 mT) for TEMPO was detected
for all compounds. However, as previously observed, the production
of <sup>1</sup>O<sub>2</sub> by the metalochlorins <bold>Ru-3A</bold> and <bold>Ru-3B</bold> was much lower (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>e).</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>EPR spectra upon irradiation with white light
of the PS in the
presence of TEMP spin trap in ethanol/DMSO at room temperature: (a) <bold>1</bold>, (b) <bold>Ru-1</bold>, (c) <bold>3B</bold>, and (d) <bold>Ru-3B</bold>. (e) TEMPO signal intensity after 15 min of irradiation.
[PS] = 1 &#x000d7; 10<sup>&#x02013;3</sup> M, [TEMP] = 4 &#x000d7; 10<sup>&#x02013;3</sup> M, blanc = spectra of TEMP without PS.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0007" id="gr9" position="float"/></fig><p>Because our compounds were producing <sup>1</sup>O<sub>2</sub> under
normal conditions, the effect of the oxygen concentration in the samples
was evaluated. Compounds <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, and <bold>Ru-3B</bold> were selected for this experiment.
Interestingly, compound <bold>Ru-1</bold> produced significant amounts
of <sup>1</sup>O<sub>2</sub> at low oxygen concentrations, which might
indicate that it could potentially be active in type II PDT on hypoxic
cancer cells.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup><xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref> shows the EPR spectra obtained at different
O<sub>2</sub> concentrations for <bold>Ru-1</bold>, and the spectra
for compounds <bold>1</bold>, <bold>3B</bold>, and <bold>Ru-3B</bold> are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">Figures S94&#x02013;S96</ext-link>,
respectively.</p><fig id="fig8" position="float"><label>Figure 8</label><caption><p>EPR spectra upon irradiation for 5 and 15 min of <bold>Ru-1</bold> in the presence of TEMP varying the oxygen concentration:
(a) 5%
of oxygen, (b) 45% of oxygen, (c) 96% of oxygen. (d) TEMPO signal
intensity for compounds <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, and <bold>Ru-3B</bold> at 15 min of irradiation at different oxygen
concentrations. [PS] = 1 &#x000d7; 10<sup>&#x02013;3</sup> M, [TEMP] =
4 &#x000d7; 10<sup>&#x02013;3</sup> M, blanc = spectra of TEMP without
PS.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0008" id="gr10" position="float"/></fig><p>Contemplating that type I PDT
can also occur when the PS is irradiated,
the possibility that the metalochlorins <bold>Ru-3A</bold> and <bold>Ru-3B</bold> can generate ROS different from <sup>1</sup>O<sub>2</sub> was investigated. Therefore, another spin trap, 5,5-dimethyl-1-pyrroline-<italic>N</italic>-oxide (DMPO), able to react with superoxide radical O<sub>2</sub><sup>&#x02022;&#x02013;</sup> was used. <xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>a&#x02013;c show the EPR spectra obtained
in the presence of DMPO before and after irradiation with white light
for 15 min. As expected, no ROS is produced without the PS (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>a). When the sample
containing the PS (<bold>Ru-3A</bold> or <bold>Ru-3B</bold>) and DMPO
was irradiated with white light for 15 min, the characteristic signal
and coupling constants for the DMPO-<sup>&#x02013;</sup> O<sub>2</sub><sup>&#x02022;&#x02013;</sup> adduct (<italic>g</italic> = 2.0060,
hfcc = 1.330 mT) were observed (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>b,c).<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> Such results confirm that our
metalochlorins can exhibit combined mechanisms of action for PDT, <italic>i.e</italic>., they can produce singlet oxygen in the type II mechanism,
as well as the superoxide radical in a type I mechanism. The Soret
band of <bold>Ru-3A</bold> and <bold>Ru-3B</bold> metalochlorins showed
a lower absorption intensity than for ligands <bold>1</bold>, <bold>2</bold>, <bold>3A</bold>, and <bold>3B</bold>, and complexes <bold>Ru-1</bold> and <bold>Ru-2</bold>. A higher Soret band absorption
intensity usually indicates a larger gap between the highest occupied
molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO),
while a lower Soret band absorption intensity means a smaller HOMO&#x02013;LUMO
gap.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> According to the literature, a small HOMO&#x02013;LUMO
gap facilitates the intermolecular transfer of photoinduced electrons
from the excited triplet state to the ground state to produce the
superoxide radical, as observed in our study.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> However, theoretical calculations in the excited states are necessary
to fully explain why the metalochlorins specifically produce superoxide
radicals.</p><fig id="fig9" position="float"><label>Figure 9</label><caption><p>EPR spectra in methanol/DMSO at room temperature: (a) DMPO in the
dark (solid line) and upon irradiation (dotted line), (b) <bold>Ru-3A</bold> in the dark (black) and upon irradiation (green), and (c) <bold>Ru-3B</bold> dark (black) and upon irradiation (green). (d) DMPO-
O<sub>2</sub><sup>&#x02022;&#x02013;</sup>signal intensity after 15
min of irradiation. [PS] = 1 &#x000d7; 10<sup>&#x02013;3</sup> M, [DMPO]
= 0.07 M. Irradiation time = 15 min.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0009" id="gr11" position="float"/></fig></sec><sec id="sec2.1.8"><title>Lipophilicity</title><p>The <italic>n</italic>-octanol/water
partition coefficient (log&#x0202f;<italic>P</italic><sub>o/w</sub>) is a well-established parameter that helps to predict the biological
activity of drugs and other biologically active compounds.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> The so-called &#x0201c;shake-flask&#x0201d; method
was adopted to determine the partition coefficient using 1-octanol
and PBS (phosphate-buffered saline) as solvents.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> The results are summarized in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. All the porphyrin derivatives presented
low lipophilicity values. At the same time, the chlorin compounds
were much more lipophilic as expected due to the reduction of one
of the pyrrole rings and the formation of the new ring in the chlorin.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Partition Coefficient (log&#x0202f;<italic>P</italic><sub>o/PBS</sub>) of Compounds<xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">compound</th><th style="border:none;" align="center" char="&#x000b1;">log&#x0202f;<italic>P</italic><sub>O/PBS</sub></th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>1</bold></td><td style="border:none;" align="char" char="&#x000b1;">0.957&#x000a0;&#x000b1;&#x000a0;0.056</td></tr><tr><td style="border:none;" align="left"><bold>Ru-1</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.014&#x000a0;&#x000b1;&#x000a0;0.058</td></tr><tr><td style="border:none;" align="left"><bold>2</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.063&#x000a0;&#x000b1;&#x000a0;0.142</td></tr><tr><td style="border:none;" align="left"><bold>Ru-2</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.032&#x000a0;&#x000b1;&#x000a0;0.108</td></tr><tr><td style="border:none;" align="left"><bold>3A</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.478&#x000a0;&#x000b1;&#x000a0;0.083</td></tr><tr><td style="border:none;" align="left"><bold>Ru-3A</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.396&#x000a0;&#x000b1;&#x000a0;0.051</td></tr><tr><td style="border:none;" align="left"><bold>3B</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.661&#x000a0;&#x000b1;&#x000a0;0.088</td></tr><tr><td style="border:none;" align="left"><bold>Ru-3B</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.510&#x000a0;&#x000b1;&#x000a0;0.177</td></tr><tr><td style="border:none;" align="left"><bold>4A</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.368&#x000a0;&#x000b1;&#x000a0;0.042</td></tr><tr><td style="border:none;" align="left"><bold>4B</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.682&#x000a0;&#x000b1;&#x000a0;0.176</td></tr><tr><td style="border:none;" align="left"><bold>VP</bold></td><td style="border:none;" align="char" char="&#x000b1;">1.374&#x000a0;&#x000b1;&#x000a0;0.064</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>The value obtained is the average
of three independent experiments at 27 &#x000b0;C.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="sec2.2"><title>Biological Assays</title><sec id="sec2.2.1"><title>Impact of
Porphyrins, Chlorins, and Ru(II) Compounds on Gastric
Cancer Cell Survival</title><p>To assess the anticancer potential of
compounds, the cytotoxicity was evaluated on the gastric cancer cell
line AGS. The cells were treated in the dark for 8 h with increasing
concentrations of the different compounds (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Cisplatin was used as a positive cytotoxic
and clinically used drug control, and verteporfin (<bold>VP</bold>) or protoporphyrin-IX (<bold>PpIX</bold>) were used as positive
PDT controls. Cells were then irradiated for 15 min with white light
or kept in the dark and further cultivated for 48h in the dark. An
MTT test was then performed to evaluate the impact of the different
treatments on cell survival. This demonstrated that in the dark, and,
in contrast to cisplatin (IC<sub>50</sub> = 29 &#x003bc;M) and verteporfin
(IC<sub>50</sub> = 7 &#x003bc;M), all compounds displayed very low toxicity
on AGS cells, with an IC<sub>50</sub> which could not be calculated,
except for <bold>Ru-1</bold> (IC<sub>50</sub> = 95 &#x003bc;M) and <bold>Ru-3A</bold> (IC<sub>50</sub> = 64 &#x003bc;M) (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, <xref rid="fig10" ref-type="fig">Figures <xref rid="fig10" ref-type="fig">10</xref></xref>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">S97&#x02013;S101</ext-link>).
After irradiation, all compounds showed a marked increase in their
toxicity, ranging between 0.1 and 4 &#x003bc;M, which, except for <bold>Ru-2</bold> (IC<sub>50</sub> = 51 &#x003bc;M), were below the IC<sub>50</sub> of cisplatin (<xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref> and <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). The difference in the observed toxicity is most likely
not due to a difference in cellular uptake, as there does not appear
to be a correlation between their lipophilicity and the IC<sub>50</sub> values. The lower cytotoxicity of <bold>Ru-2</bold> is most likely
due to its low stability in biological media, as determined by stability
tests in PBS/DMSO. The phototoxicity index (PI) was calculated based
on the IC<sub>50</sub> dark/light ratio, and values as high as 1000
and 555 were calculated for compounds <bold>3A</bold> and <bold>3B</bold>, respectively.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p><fig id="fig10" position="float"><label>Figure 10</label><caption><p>(a) Graphs showing the
mean IC<sub>50</sub> inhibitory concentrations
presented in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. Student&#x02019;s <italic>t</italic>-test is considered significant
at <italic>p</italic> &#x0003c; 0.5. * &#x0003c; 0.05, ** &#x0003c; 0.01, *** &#x0003c;
0.001, **** &#x0003c; 0.0001 with respect to cisplatin. (b) Comparison
of the minimum inhibitory concentration in the dark and activated
under irradiation with white light for 15 min.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0010" id="gr12" position="float"/></fig><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Mean Inhibitory Concentrations (IC<sub>50</sub>) of
the Compounds in AGS Gastric Cancer Cells<xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="3" align="center">IC<sub>50</sub> (&#x003bc;M)<hr/></th></tr><tr><th style="border:none;" align="center">compound</th><th style="border:none;" align="center">light</th><th style="border:none;" align="center">dark</th><th style="border:none;" align="center">PI</th></tr></thead><tbody><tr><td style="border:none;"><bold>cisplatin</bold></td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">29</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;"><bold>PpIX</bold></td><td style="border:none;" align="left">0.5</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;200</td></tr><tr><td style="border:none;"><bold>Vp</bold></td><td style="border:none;" align="left">0.003</td><td style="border:none;" align="left">7</td><td style="border:none;" align="left">=13,270</td></tr><tr><td style="border:none;"><bold>1</bold></td><td style="border:none;" align="left">1.7&#x000a0;&#x000b1;&#x000a0;0.184</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;17</td></tr><tr><td style="border:none;"><bold>Ru-1</bold></td><td style="border:none;" align="left">3.8&#x000a0;&#x000b1;&#x000a0;0.379</td><td style="border:none;" align="left">95&#x000a0;&#x000b1;&#x000a0;0.462</td><td style="border:none;" align="left">=25</td></tr><tr><td style="border:none;"><bold>2</bold></td><td style="border:none;" align="left">2.6&#x000a0;&#x000b1;&#x000a0;0.100</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;18</td></tr><tr><td style="border:none;"><bold>Ru-2</bold></td><td style="border:none;" align="left">51.3&#x000a0;&#x000b1;&#x000a0;1.249</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;2</td></tr><tr><td style="border:none;"><bold>3A</bold></td><td style="border:none;" align="left">0.1&#x000a0;&#x000b1;&#x000a0;0.06</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;1000</td></tr><tr><td style="border:none;"><bold>Ru-3A</bold></td><td style="border:none;" align="left">1.7&#x000a0;&#x000b1;&#x000a0;0.100</td><td style="border:none;" align="left">64.1&#x000a0;&#x000b1;&#x000a0;0.815</td><td style="border:none;" align="left">=38</td></tr><tr><td style="border:none;"><bold>3B</bold></td><td style="border:none;" align="left">0.2&#x000a0;&#x000b1;&#x000a0;0.021</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;555</td></tr><tr><td style="border:none;"><bold>Ru-3B</bold></td><td style="border:none;" align="left">3.2&#x000a0;&#x000b1;&#x000a0;0.252</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;31</td></tr><tr><td style="border:none;"><bold>4A</bold></td><td style="border:none;" align="left">2.5&#x000a0;&#x000b1;&#x000a0;0.231</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;40</td></tr><tr><td style="border:none;"><bold>4B</bold></td><td style="border:none;" align="left">2.8&#x000a0;&#x000b1;&#x000a0;0.265</td><td style="border:none;" align="left">&#x0003e;100</td><td style="border:none;" align="left">&#x0003e;36</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Cells were incubated for 8 h, followed
by irradiation with white light for 15 min or kept in dark condition.
The MTT assay was performed to determine cell viability after 48 h
of treatment. <italic>N</italic> = 3.</p></fn></table-wrap-foot></table-wrap><p>Given these results, compounds <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, and <bold>Ru-3B</bold> were selected
as lead compounds
for further studies. <bold>Ru-3B</bold> complex is of special interest
as it could present different PDT mechanisms, combining the production
of <sup>1</sup>O<sub>2</sub> by the type II mechanism and O<sub>2</sub><sup>&#x02022;<bold>&#x02013;</bold></sup> radicals by a type I mechanism
(as mentioned above). This capacity might be of significant importance
for the design of new PS since the production of O<sub>2</sub><sup>&#x02022;<bold>&#x02013;</bold></sup> radicals does not directly depend
on the concentration of oxygen present in the hypoxic microenvironment
of cancer cells.<sup><xref ref-type="bibr" rid="ref59">59</xref>&#x02212;<xref ref-type="bibr" rid="ref61">61</xref></sup></p></sec><sec id="sec2.2.2"><title>Induction of Cell Deaths by Porphyrins, Chlorins,
and Ruthenium
Compounds</title><p>The therapeutic effects of PDT treatment on cancer
cells are thought to be mainly related to ROS production, which are
highly reactive and cytotoxic species that can induce cell death by
apoptosis.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> It has also been shown that
ruthenium compounds can induce different cell death pathways.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref64">64</xref></sup> For these reasons, we initially analyzed by Western blot the expression
of cleaved caspase 3 and PARP, which are two well-known markers for
programmed cell death apoptosis.<sup><xref ref-type="bibr" rid="ref65">65</xref>&#x02212;<xref ref-type="bibr" rid="ref70">70</xref></sup> For this, AGS cells were treated at the IC<sub>50</sub> of each
compound for 4 h in the dark and then irradiated, or not, with white
light for 15 min. The cells were then further cultivated in the dark
for 24 h. <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref> shows that, except for <bold>PpIX</bold>, all compounds induced
the cleavage of caspase 3 and PARP after irradiation, notably compound <bold>1</bold>, which was as efficient as <bold>VP</bold>. Then, the protein
expression of CHOP, a key component of the endoplasmic reticulum (ER)
stress-mediated apoptosis pathway and known to be induced by ruthenium
compounds, was evaluated.<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref72">72</xref></sup> All compounds, except
for <bold>PpIX</bold>, induced the expression of CHOP upon irradiation.
Interestingly, CHOP expression was much more strongly induced by the
ruthenium compounds compared to their respective free ligands or verteporfin,
suggesting that they possibly lead to a much stronger accumulation
of misfolded or unfolded proteins and/or ROS production (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>).<sup><xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> Furthermore, CHOP has been reported to participate in the regulation
of ER stress-mediated autophagy.<sup><xref ref-type="bibr" rid="ref75">75</xref>&#x02212;<xref ref-type="bibr" rid="ref77">77</xref></sup> Autophagy is a cellular
self-degradation system that facilitates the degradation of damaged
organelles and misfolded or mutant proteins.<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> In cancer, autophagy protects tumor cells during cancer progression.
However, it can also suppress cancer cell development or induce cell
death.<sup><xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref80">80</xref></sup> Autophagy is characterized by the formation
of autophagosomes, which express LC3B proteins. To investigate this,
the expression and conversion of LC3B&#x02013;I to LC3B&#x02013;II was
analyzed by Western blot (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>). The results show that following irradiation, all
ruthenium compounds induced the expression of LC3B&#x02013;I and LC3B&#x02013;II
(<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>). Interestingly,
upon light activation, <bold>3B</bold> and <bold>Ru-3B</bold> led
to a marked induction of LC3B&#x02013;I/II expression, similar to verteporfin,
suggesting a specific induction of autophagy (<xref rid="fig11" ref-type="fig">Figures <xref rid="fig11" ref-type="fig">11</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">S102</ext-link>)</p><fig id="fig11" position="float"><label>Figure 11</label><caption><p>Effects of
photoactivation of <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, and <bold>Ru-3B</bold> on protein expression on
different cell death markers in AGS gastric cancer cells. AGS cells
were treated with <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, <bold>Ru-3B, PpIX</bold>, or <bold>VP</bold> at IC<sub>50</sub> concentrations for 4 h and then either irradiated with white light
or kept in the dark for 15 min and then further cultivated for 24
h in the dark. Protein extraction was performed, and expression of
the different markers was determined by Western blot. GAPDH was used
as a loading control. Representative Western blot of three independent
experiments. ctl = control, untreated cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0011" id="gr13" position="float"/></fig><p>Ferroptosis, another form of nonapoptotic cell death, can promote
inflammation and is triggered by iron-catalyzed lipid peroxidation <italic>via</italic> Fenton-type reactions, where the main ROS responsible
for lipid damage are hydroxyl radical and superoxide radical.<sup><xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref82">82</xref></sup> Glutathione peroxidase (GPX4) can suppress lipid peroxidation and
protect cells from ferroptosis.<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> To investigate
the impact of the different compounds on GPX4 expression, AGS cells
were treated as described above, and then GPX4 expression was analyzed
by Western blot (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>a). This showed that upon activation by light, <bold>PpIX</bold> and <bold>Ru-3B</bold> lead to a decrease in GPX4 expression (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>a,b), which suggests
that these two compounds might induce ferroptosis.</p><fig id="fig12" position="float"><label>Figure 12</label><caption><p>Effects of photoactivation
of <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold> and <bold>Ru-3B</bold> on protein expression of
ferroptosis and inflammation markers in AGS gastric cancer cells.
AGS cells were treated with <bold>1</bold>, <bold>Ru-1</bold>, <bold>3B</bold>, <bold>Ru-3B, PpIX</bold>, or <bold>VP</bold> at IC<sub>50</sub> concentrations for 4 h and then either irradiated with white
light or kept in the dark for 15 min and then further cultivated for
24 h in the dark. (a) Expression of the different markers was determined
by Western blot. GAPDH was used as a loading control. Representative
Western blot of three independent experiments. ctl = control, untreated
cells. Graphs represent the quantification of three independent experiments
of GPX4 (b) and COX2 (c) expression, compared to not-treated AGS cells
(ctl) and normalized to GAPDH expression. Bars above the colons indicate
the comparison of dark <italic>versus</italic> light for each compound.
The dark and light results of each compound were compared to those
of the respective untreated control condition (ctl). Statistical analysis:
2-way Anova *&#x0003c;0.05, **&#x0003c;0.01, ***&#x0003c;0.001, ns = not-significant.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_0012" id="gr14" position="float"/></fig><p>COX2 is known for its central role in inflammation
and prostaglandins
(PGs) production. In normal cells, COX2 expression is almost absent,
whereas in cancer cells, it is frequently overexpressed.<sup><xref ref-type="bibr" rid="ref84">84</xref></sup> Importantly, it has been shown that in cancers,
COX2 is not only a mediator of inflammation but could also be a mediator
of oxidative stress and inhibition of apoptosis, as well as cancer
cell proliferation.<sup><xref ref-type="bibr" rid="ref85">85</xref></sup> The expression of
COX2 was analyzed by Western blot (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>a), showing that upon light irradiation,
compounds <bold>1</bold> and <bold>Ru-1</bold> significantly reduce
COX2 expression compared to untreated conditions. In contrast, <bold>PpIX</bold>, <bold>3B</bold>, <bold>Ru-3B</bold>, and <bold>VP</bold> already lead to a reduction in COX2 expression in the dark (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>a,c). These results
suggest that the effect of <bold>PpIX</bold>, <bold>3B</bold>, <bold>Ru-3B</bold>, and <bold>VP</bold> on cell survival upon light activation
may not be due to their repressive influence on COX2 expression.</p></sec></sec></sec><sec id="sec3"><title>Conclusions</title><p>A series of tetrapyrrole-ruthenium(II)
compounds derived from protoporphyrin
IX and the commercial drug verteporfin were designed as potential
photosensitizers for PDT. The introduction of the ruthenium atom in
the central cavity of the macrocycle did not affect the low toxicity
in the dark on human gastric cancer cells compared to the free ligands
while displaying remarkable cytotoxicity upon irradiation with light.
Additionally, our results show that the complexes could cause cell
death under low oxygen concentrations by generating singlet oxygen
or superoxide anion radicals. Notably, the ruthenium atom coordinated
to the chlorin ligands allowed combined mechanisms since EPR studies
showed that both singlet oxygen and superoxide radicals could be produced
by complexes <bold>Ru-3A</bold> and <bold>Ru-3B</bold> after irradiation.
The ruthenium complex <bold>Ru-1</bold> also produced large amounts
of singlet oxygen at very low oxygen concentrations. Such results
are significant since these new photosensitizers could be used for
PDT in hypoxic environments, as often found in tumors. In addition,
the study demonstrates that upon light activation, the ruthenium derivatives
not only induce cell death <italic>via</italic> a caspase 3 mediated
apoptotic pathway, but also partly <italic>via</italic> CHOP, which
is an endoplasmic reticulum (ER) stress-inducible transcription factor
involved in the development of apoptosis and growth arrest. These
data confirm that the new ruthenium compounds can be tuned to trigger
various cell death pathways and highlight the potential of our complexes
as promising multitarget therapeutic alternatives that could reduce
tumor resistance mechanisms.</p></sec><sec id="sec4"><title>Experimental Section</title><sec id="sec4.1"><title>Chemistry</title><sec id="sec4.1.1"><title>Reagents
and Measurements</title><p>The compounds were synthesized
using a double vacuum/inert gas line under a nitrogen or argon atmosphere.
All solvents were dried using established procedures and distilled
under nitrogen prior to use. All reagents were purchased from Sigma-Aldrich
and were used without prior purification. RuCl<sub>3</sub> was purchased
from Pressure Chemical Company. Ruthenium precursor [Ru<sub>3</sub>(CO)<sub>l2</sub>] was prepared according to previously reported
procedures.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup></p><p>The reactions were
monitored by thin layer chromatography (TLC) using silica gel 60 F<sub>254</sub> alumina plates (Merck). Infrared spectra were recorded
on an &#x003b1; ATR spectrometer from Bruker Optics. Mass spectra (FAB<sup>+</sup>) were obtained using a Jeol JMS-SX102A instrument with <italic>m</italic>-nitrobenzyl alcohol as the matrix. Electrospray ionization
mass spectrometry (ESI-MS) was performed using a Bruker Esquire spectrometer.
The NMR spectra were recorded at room temperature using deuterated
chloroform, acetone, or acetonitrile as solvent on a Bruker Advance
spectrometer at 300 MHz for proton and 75 MHz for carbon and on a
Bruker Advance spectrometer at 500 MHz for proton and 125 MHz for
carbon. Chemical shifts (&#x003b4;) are in ppm downfield of TMS using
the residual solvent as an internal standard. Coupling constants (<italic>J</italic>) are expressed in Hz. Multiplicity: s = singlet, d = doublet,
t = triplet, sept = septuplet, m = multiplet. The UV&#x02013;vis absorption
spectra were recorded on a Shimadzu 2600 spectrophotometer in a quartz
cuvette at 37 &#x000b0;C with 1 &#x000d7; 10<sup>&#x02013;5</sup> M solutions
of each compound in DMSO (prepared from a 10 mM stock solution). The
fluorescence spectra were obtained in an Agilent Varian Cary 100 spectrophotometer
in quartz cuvettes at room temperature. Electron paramagnetic resonance
(EPR) determinations were carried out in an EPR spectrometer (Jeol
JES-TE300), operated in the X-Band mode at a modulation frequency
of 100 kHz with a cylindrical cavity (TE<sub>011</sub>). Each sample
was placed in a quartz flat cell (Wilmad Glass Company) and irradiated <italic>in situ</italic>. The photogeneration of <sup>1</sup>O<sub>2</sub> was carried out with a 500 Hg Arc lamp (Oriel OPS-A500), and the
samples were irradiated continuously at 160 W. Data acquisition and
manipulation were done using the ES-IPRIT/TE program. The HPLC chromatograms
were recorded on an Agilent model 1200 Series Binary SL system with
a UV&#x02013;vis detector (&#x003bb; = 400 nm) and an Eclipse Plus C<sub>18</sub> (3.5 &#x003bc;m &#x000d7; 2.1 mm) column. The flow rate was 0.2
mL/min, with the initial mobile phase acetonitrile&#x02013;water (60:40)
for the first 10 min. Then acetonitrile&#x02013;water (90:10) for 20
min and finally acetonitrile for 20 min.</p></sec></sec><sec id="sec4.2"><title>Synthesis of the Ligands</title><sec id="sec4.2.1"><title>Synthesis
of Porphyrin Derivatives</title><sec id="sec4.2.1.1"><title>Porphyrin <bold>1</bold></title><p>The esterification
reaction
was carried out by adapting a reported procedure.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> A solution of 95.0 mL of dry methanol and 5.0 mL of H<sub>2</sub>SO<sub>4</sub> at 5% (v/v) was cooled to &#x02212;20 &#x000b0;C
in a cold bath, and 1.0 g (1.648 mmol) of the disodium salt of the
protoporphyrin IX (<bold>Na</bold><sub><bold>2</bold></sub><bold>-PpIX</bold>) was added. The reaction mixture was stirred overnight at &#x02212;18
&#x000b0;C in the dark. The solution was neutralized with a 10% aqueous
solution of NaHCO<sub>3</sub>, and the organic phase was extracted
with 200 mL of CHCl<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated to dryness under vacuum, and
the crude solid was purified by column chromatography (silica gel,
(1/10) ethyl acetate/dichloromethane) to give 954 mg of a purple solid
in 98% yield. The purity observed by HPLC is &#x0003e;99%.</p><p>MS (FAB<sup>+</sup>) <italic>m</italic>/<italic>z</italic> (%) 591 (30) [C<sub>36</sub>H<sub>38</sub>N<sub>4</sub>O<sub>4</sub> + H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;&#x02013;NH 3039, &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2913, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2852, &#x003bd;&#x02013;C=O (ester) 1731. UV&#x02013;vis
(DMSO, &#x003bb;<sub>max</sub> nm) (log &#x003b5;): &#x003bb;<sub>1</sub> (Soret) 406 (4.48), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 506 (4.43),
&#x003bb;<sub>3</sub> (Q<sub>III</sub>) 540 (3.33), &#x003bb;<sub>4</sub> (Q<sub>II</sub>) 576 (3.12), &#x003bb;<sub>5</sub> (Q<sub>I</sub>)
630 (2.97). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): &#x02212;3.84
(s, 2H, NH); 3.27 (t, 4H, <sup>3</sup><italic>J</italic> = 7.75, H-22
and H-25); 3.59, 3.60, 3.67, and 3.68 (4s, 18 H, H-17, H-18, H-19,
H-20, O&#x02013;CH<sub>3</sub> and O&#x02013;CH<sub>3</sub>); 4.38 (t,
4H, <sup>3</sup><italic>J</italic> = 7.71, H-21 and H-24); 6.18 (dd,
2H, <italic>J</italic><sub>AB</sub> = 1.06, <italic>J</italic><sub>AX</sub> = 11.57, H<sub>A</sub>); 6.36 (dd, 2H, <italic>J</italic><sub>BA</sub> = 1.05 Hz, <italic>J</italic><sub><italic>BX</italic></sub> = 17.74 Hz, H<sub>B</sub>); 8.25 (m, 2H, H<sub>X</sub>); 9.97,
10, 10.11, and 10.13 (4s, 4H, H-&#x003b1;, H-&#x003b2;, H-&#x003b3; and
H-&#x003b4;). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): 11.81,
12.84, 21.96, 37.06, 51.89, 96.19, 97.18, 97.50, 98.10, 120.90, 130.42,
173.73. The atoms were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec><sec id="sec4.2.1.2"><title>Porphyrin <bold>2</bold></title><p>The esterification reaction
was carried out by adapting a reported procedure.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>A solution of 2.0 mL of benzyl alcohol and 0.5 mL
of 1.0 N HCl was cooled to &#x02212;20 &#x000b0;C in a cold bath, and
70 mg (0.115 mmol) of the disodium salt of the protoporphyrin IX (<bold>Na</bold><sub><bold>2</bold></sub><bold>-PpIX</bold>) was added.
The reaction mixture was stirred overnight at &#x02212;18 &#x000b0;C in
the dark. The solution was neutralized with a 10% aqueous solution
of NaHCO<sub>3</sub>, and the organic phase was extracted with 100
mL of CHCl<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated to dryness under vacuum, and the crude
solid was purified by column chromatography (silica gel, (6/4) ethyl
acetate/dichloromethane) to give 76 mg of a purple solid in 89% yield.
The purity observed by HPLC is &#x0003e;99%.</p><p>MS (FAB<sup>+</sup>) <italic>m</italic>/<italic>z</italic> (%)
743 (15) [C<sub>48</sub>H<sub>46</sub>N<sub>4</sub>O<sub>4</sub> +
H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;&#x02013;NH
3306, &#x003bd;<sub>as</sub>&#x02013;CH3 2909, &#x003bd;<sub>s</sub>&#x02013;CH3
2854, &#x003bd;&#x02013;C=O (ester) 1735. UV&#x02013;vis (DMSO,
&#x003bb;<sub>max</sub> nm) (log &#x003b5;): &#x003bb;<sub>1</sub> (Soret)
408 (4.76), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 506 (3.87), &#x003bb;<sub>3</sub> (Q<sub>III</sub>) 540 (3.77), &#x003bb;<sub>4</sub> (Q<sub>II</sub>) 576 (3.56), &#x003bb;<sub>5</sub> (Q<sub>I</sub>) 630 (3.41). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): &#x02212;3.87 (s, 2H, NH);
3.30 (t, 4H, <sup>3</sup><italic>J</italic> = 7.55, H-22 and H-25);
3.55 and 3.67 (2s, 12 H, H-17, H-18, H-19 and H-20); 4.38 (t, 4H, <sup>3</sup><italic>J</italic> = 7.51, H-21 and H-24); 5.04 (s, 4H, Ph&#x02013;CH<sub>2</sub>); 6.18 (dd, 2H, <italic>J</italic><sub>AB</sub> = 1.01, <italic>J</italic><sub>AX</sub> = 11.56, H<sub>A</sub>); 6.37 (dd, 2H, <italic>J</italic><sub>BA</sub> = 1.68, <italic>J</italic><sub>BX</sub> =
17.80, H<sub>B</sub>); 7.03 (m, 10H, Ph-H); 8.25 (dd, 2H, <italic>J</italic><sub>XA</sub> = 11.44, <italic>J</italic><sub>XB</sub> =
17.17, H<sub>X</sub>); 9.96, 9.97, 10.07, and 10.13 (4s, 4H, H-&#x003b1;,
H-&#x003b2;, H-&#x003b3; and H-&#x003b4;). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): 11.83, 12.87, 21.94, 37.18, 66.51, 96.37, 97.25,
97.56, 98.11, 120.93, 128.07, 128.14, 128.41, 130.44, 135.84, 173.14.
The atoms were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec></sec><sec id="sec4.2.2"><title>Synthesis of Chlorin Derivatives</title><p>The Diels&#x02013;Alder
reaction was carried out by modifying a reported procedure.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Dimethyl acetylenedicarboxylate (1.0 mL, 0.008 mol) was added to
a solution of 100 mg of the porphyrin <bold>1</bold> or <bold>2</bold> in 5 mL of chloroform. The reaction mixture was heated to reflux
temperature for 72 h with constant stirring. The reaction was concentrated
under vacuum, and the two isomers were separated by silica gel chromatography
using dichloromethane/hexane/ethyl acetate as eluent (8:1.2:0.8).</p><sec id="sec4.2.2.1"><title>Chlorin <bold>3A</bold></title><p>Dark blue solid, 19 mg, 21%
yield. The purity observed by HPLC is &#x0003e;99%. MS (ESI) <italic>m</italic>/<italic>z</italic> 733 [C<sub>42</sub>H<sub>44</sub>N<sub>4</sub>O<sub>8</sub>+H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;&#x02013;NH
3334, &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2948, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2856, &#x003bd;&#x02013;C=O (ester)
1721. UV&#x02013;vis (DMSO, &#x003bb;<sub>max</sub> nm) (log &#x003b5;):
&#x003bb;<sub>1</sub> (Soret) 406 (4.92), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 502 (4.05), &#x003bb;<sub>3</sub> (Q<sub>III</sub>) 536 (3.94),
&#x003bb;<sub>4</sub> (Q<sub>II</sub>) 608 (3.60), &#x003bb;<sub>5</sub> (Q<sub>I</sub>) 666 (4.51). <sup>1</sup>H NMR (CDCl<sub>3</sub>,
300 MHz): &#x02212;2.63 (s, 2H, NH); 2.11 (s, 3H, H-18); 3.26 (t, 2H, <italic>J</italic> = 7.79, H-25); 3.24 (t, 2H, <italic>J</italic> = 7.85,
H-22); 3.37 (s, 3H, H-19); 3.52 (a, 3H, H-20); 3.54 (s, 3H, H-17);
3.60 (dd, 1H, <italic>J</italic> = 1.90, H-28); 3.68 (s, 3H, O&#x02013;CH<sub>3</sub>); 3.69 (s, 3H, O&#x02013;CH<sub>3</sub>); 3.93 (s, 3H, H-31);
4.02 (dd, 1H, <italic>J</italic> = 6.67, H-28); 4.07 (s, 3H, H-32);
4.16 (t, 2H, <italic>J</italic> = 7.61, H-24); 4.36 (t, 2H, <italic>J</italic> = 7.23, H-21); 6.14 (dd, 1H, <italic>J</italic><sub>AB</sub> = 1.46, <italic>J</italic><sub>AX</sub> = 11.51, H<sub>A</sub>);
6.32 (dd, 1H, <italic>J</italic><sub>BA</sub> = 1.43, <italic>J</italic><sub>BX</sub> = 17.84, H<sub>B</sub>); 7.39 (dd, 1H, <italic>J</italic> = 1.97, <italic>J</italic> = 6.61, H-27); 8.11 (dd, 1H, <italic>J</italic><sub>XA</sub> = 11.49, <italic>J</italic><sub>XB</sub> =
17.79, H<sub>X</sub>); 9.13 (s, 1H, H-&#x003b4;); 9.34 (s, 1H, H-&#x003b1;);
9.74 (s, 1H, H-&#x003b3;); 9.76 (s, 1H, H-&#x003b2;). <sup>13</sup>C NMR
(CDCl<sub>3</sub>, 75 MHz): 11.54, 11.73, 12.40, 21.71, 21.95, 28.33,
29.95, 36.78, 37.17, 51.82, 51.93, 52.57, 52.73, 54.93, 90.54, 92.44;
99.03, 99.49, 118.39, 121.63, 128.77, 129.76, 129.86, 130.58, 133.19,
133.22, 134.16, 136.26, 137.28, 138.08, 138.26, 140.05, 149.25, 149.35,
150.56, 151.93, 152.22, 162.39, 166.21, 170.28, 173.52, 173.90. The
atoms were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec><sec id="sec4.2.2.2"><title>Chlorin <bold>3B</bold></title><p>Brown solid, 61 mg, 68% yield.
The purity observed by HPLC is &#x0003e;99%. MS (ESI) <italic>m</italic>/<italic>z</italic> 733 [C<sub>42</sub>H<sub>44</sub>N<sub>4</sub>O<sub>8</sub>+H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;&#x02013;NH
3339, &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2957, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2854, &#x003bd;&#x02013;C=O (ester)
1717. UV&#x02013;vis (DMSO, &#x003bb;<sub>max</sub> nm) (log &#x003b5;):
&#x003bb;<sub>1</sub> (Soret) 404 (5.03), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 500 (4.07), &#x003bb;<sub>3</sub> (Q<sub>III</sub>) 534 (3.93),
&#x003bb;<sub>4</sub> (Q<sub>II</sub>) 608 (3.62), &#x003bb;<sub>5</sub> (Q<sub>I</sub>) 666 (4.55). <sup>1</sup>H NMR (CDCl<sub>3</sub>,
300 MHz): &#x02212;2.48 (s, 2H, NH); 2.11 (s, 3H, H-18); 3.20 (2 t,
superimposed, 4H; H-22 and H-25); 3.42 (s, 3H, H-20); 3.49 (s, 3H,
H-17); 3.62 (dd, 1H, <italic>J</italic> = 1.88, <italic>J</italic> = 21.03, H-28); 3.66 (s, 6H, O&#x02013;CH<sub>3</sub>); 3.67 (s,
3H, H-19); 3.91 (s, 3H, H-31); 3.98 (dd, 1H, <italic>J</italic> =
6.68, <italic>J</italic> = 21.07, H-28); 4.01 (s, 3H, H-32); 4.17
(t, 2H, <sup>3</sup><italic>J</italic> = 7.54, H-21); 4.31 (t, 2H, <sup>3</sup><italic>J</italic> = 7.57, H-24); 6.17 (dd, 1H, <italic>J</italic><sub>AX</sub> = 11.62, H<sub>A</sub>); 6.34 (dd, 1H, <italic>J</italic><sub>BX</sub> = 17.78, H<sub>B</sub>); 7.39 (dd; 1H, <sup>3</sup><italic>J</italic> = 6.37, H-27); 8.18 (dd, 1H; <italic>J</italic><sub>XA</sub> = 11.55, <italic>J</italic><sub>XB</sub> = 17.79, H<sub>X</sub>); 9.22 (s, 1H; H-&#x003b1;); 9.31 (s, 1H, H-&#x003b2;); 9.66
(s, 1H, H-&#x003b3;); 9.80 (s, 1H, H-&#x003b4;). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz): 11.43, 11.80, 12.78, 21.67, 21.98, 28.33, 29.96,
36.74, 37.17, 51.83, 51.92, 52.71, 52.75, 54.82, 90.11, 92.77, 98.25,
100.42, 118.77, 120.87, 128.52, 129.72, 130.77, 131.10, 133.28, 133.32,
134.14, 136.51, 136.90, 138.25, 138.52, 139.75, 149.31, 149.39, 151.03,
151.27, 153.03, 162.31, 166.19, 170.21, 173.50, 173.92. The atoms
were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec><sec id="sec4.2.2.3"><title>Chlorin <bold>4A</bold></title><p>Dark blue
solid, 7 mg, 19%
yield. The purity observed by HPLC is &#x0003e;99%. MS (ESI) <italic>m</italic>/<italic>z</italic> 885 [C<sub>54</sub>H<sub>52</sub>N<sub>4</sub>O<sub>8</sub>+H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;&#x02013;NH
3341, &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2953, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2850, &#x003bd;&#x02013;C=O (ester)
1718. UV&#x02013;vis (DMSO, &#x003bb;<sub>max</sub> nm) (log &#x003b5;):
&#x003bb;<sub>1</sub> (Soret) 406 (5.01), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 502 (3.97), &#x003bb;<sub>3</sub> (Q<sub>III</sub>) 536 (3.87),
&#x003bb;<sub>4</sub> (Q<sub>II</sub>) 608 (3.60), &#x003bb;<sub>5</sub> (Q<sub>I</sub>) 666 (4.42). <sup>1</sup>H NMR (CDCl<sub>3</sub>,
300 MHz): &#x02212;2.58 (s, 2H, NH); 2.11 (s, 3H, H-18); 3.24 (2 t,
superimposed, 4H, H-22 and H-25); 3.37 (s, 3H, H-20); 3.48 (s, 3H,
H-19); 3.59 (s, 3H, H-17); 3.67 (dd, 1H, <italic>J</italic> = 1.76,
H-28); 3.91 (s, 3H, H-31); 4.00 (dd, 1H, <italic>J</italic> = 6.76,
H-28); 4.01 (s, 3H, H-32); 4.20 (t, 2H, <sup>3</sup><italic>J</italic> = 7.52, H-21); 4.35 (t, 2H, <sup>3</sup><italic>J</italic> = 7.61,
H-24); 5.04 (s, 4H, Ph&#x02013;CH<sub>2</sub>); 6.17 (dd, 1H, <italic>J</italic><sub>AB</sub> = 1.15, <italic>J</italic><sub>AX</sub> =
11.60, H<sub>A</sub>); 6.37 (dd, 1H, <italic>J</italic><sub>BA</sub> = 1.46, <italic>J</italic><sub>BX</sub> = 17.87, H<sub>B</sub>);
7.06 (m, 10H; Ph-H); 7.41 (dd; 1H, <italic>J</italic> = 1.75, <italic>J</italic> = 6.42, H-27); 8.18 (dd, 1H; <italic>J</italic><sub>XA</sub> = 11.52, <italic>J</italic><sub>XB</sub> = 17.73, H<sub>X</sub>);
9.09 (s, 1H; H- &#x003b4;); 9.39 (s, 1H, H-&#x003b1;); 9.77 (s, 1H, H-&#x003b3;);
9.82 (s, 1H, H-&#x003b2;). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75
MHz): 11.45, 11.81, 12.79, 21.65, 21.97; 28.32, 29.97, 36.88, 37.30,
52.72, 52.76, 54.82, 66.43; 66.55, 90.15, 92.74, 98.42, 100.47, 118.73,
120.86, 124.95, 128.05, 128.53, 129.75, 130.74, 131.18, 133.25, 133.31,
134.19, 136.23, 136.88, 138.25, 138.62, 139.74, 149.34, 149.41, 151.05,
151.36, 153.00, 162.28, 166.21, 170.23, 172.94, 173.35. The atoms
were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec><sec id="sec4.2.2.4"><title>Chlorin <bold>4B</bold></title><p>Brown solid,
17 mg, 44% yield.
The purity observed by HPLC is &#x0003e;99%. MS (ESI) <italic>m</italic>/<italic>z</italic> 885 [C<sub>54</sub>H<sub>52</sub>N<sub>4</sub>O<sub>8</sub> + H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>):
&#x003bd;&#x02013;NH
3341, &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2923, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2852, &#x003bd;&#x02013;C=O (ester)
1719. UV&#x02013;vis (DMSO, &#x003bb;<sub>max</sub> nm) (log&#x0202f;&#x003b5;):
&#x003bb;<sub>1</sub> (Soret) 406 (4.99), &#x003bb;<sub>2</sub> (Q<sub>IV</sub>) 502 (4.10), &#x003bb;<sub>3</sub> (Q<sub>III</sub>) 534 (3.94),
&#x003bb;<sub>4</sub> (Q<sub>II</sub>) 608 (3.60), &#x003bb;<sub>5</sub> (Q<sub>I</sub>) 666 (4.59). <sup>1</sup>H NMR (CDCl<sub>3</sub>,
300 MHz): &#x02212;2.55 (s, 2H, NH); 2.04 (s, 3H, H-18); 3.15 (2 t,
superimposed, 4H, H-22 and H-25); 3.31 (s, 3H, H-20); 3.37 (s, 3H,
H-19); 3.55 (dd, 1H, <italic>J</italic> = 1.97, H-28); 3.59 (s, 3H,
H-17); 3.82 (s, 3H, H-31); 3.90 (dd, 1H, <italic>J</italic> = 6.66, <italic>J</italic> = 22.15, H-28); 3.94 (s, 3H, H-32); 4.11 (t, 2H, <sup>3</sup><italic>J</italic> = 7.52, H-21); 4.24 (t, 2H, <sup>3</sup><italic>J</italic> = 7.61, H-24); 4.94 (s, 2H, Ph&#x02013;CH<sub>2</sub>); 4.97 (s, 2H, Ph&#x02013;CH<sub>2</sub>); 6.10 (dd, 1H, <italic>J</italic><sub>AB</sub> = 1.43, <italic>J</italic><sub>AX</sub> =
11.54, H<sub>A</sub>); 6.26 (dd, 1H, <italic>J</italic><sub><italic>BA</italic></sub> = 1.43, <italic>J</italic><sub>BX</sub> = 17.88,
H<sub>B</sub>); 6.95&#x02013;7.07 (m, 10H, Ph-H); 7.31 (dd; 1H, <italic>J</italic> = 2.01, <italic>J</italic> = 6.68, H-27); 8.11 (dd, 1H; <italic>J</italic><sub>XA</sub> = 11.57, <italic>J</italic><sub>XB</sub> =
17.84, H<sub>X</sub>); 9.15 (s, 1H, H-&#x003b1;); 9.21 (s, 1H, H-&#x003b2;);
9.60 (s, 1H, H-&#x003b3;); 9.71 (s, 1H, H-&#x003b4;). <sup>13</sup>C NMR
(CDCl<sub>3</sub>, 75 MHz): 11.45, 11.81, 12.79, 21.65, 21.97, 28.32,
29.97, 36.88, 37.30, 52.72, 52.76, 54.82, 66.43, 66.55, 90.15, 92.74,
98.42, 100.47, 118.73, 120.86, 124.95, 128.05, 128.53, 129.75, 130.74,
131.18, 133.25, 133.31, 134.19, 136.23, 136.88, 138.25, 138.62, 139.74,
149.34, 149.41, 151.05, 151.36, 153.00, 162.28, 166.21, 170.23, 172.94,
173.35. The atoms were numbered according to <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>.</p></sec></sec><sec id="sec4.2.3"><title>Synthesis of the Complexes</title><sec id="sec4.2.3.1"><title>General
Procedure</title><p>The ruthenium complexes were prepared
by adapting a reported procedure.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> A solution
of 1.0 mmol of the corresponding ligand (<bold>1</bold>, <bold>2</bold>, <bold>3A</bold>, and <bold>3B</bold>) and 1.1 mmol of [Ru<sub>3</sub>(CO)<sub>12</sub>] in 10 mL of benzene was stirred at reflux temperature
for 24 h in the dark. The solvent was evaporated to dryness under
vacuum, and the crude solid was purified through column chromatography
on neutral alumina using a 1:2 hexane/acetone mixture as eluent.</p><p><bold>Ru-1</bold>: A pink solid was obtained from 30.0 mg (0.051
mmol) of <bold>1</bold> and 36.0 mg (0.056 mmol) of [Ru<sub>3</sub>(CO)<sub>12</sub>] in 78% yield (28 mg). The purity observed by HPLC
is &#x0003e;99%. MS (FAB<sup>+</sup>) <italic>m</italic>/<italic>z</italic> 718 [C<sub>37</sub>H<sub>36</sub>N<sub>4</sub>O<sub>5</sub>Ru +
H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2921, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2858, &#x003bd;&#x02013;Ru&#x02013;C=O 1914, &#x003bd;&#x02013;C=O
(ester) 1744. UV&#x02013;vis (DMSO, &#x003bb;max nm) (log&#x0202f;&#x003b5;):
&#x003bb;<sub>1</sub> (Soret) 404 (4.76), &#x003bb;<sub>2</sub> (Q<sub>&#x003b2;</sub>) 524 (4.08), &#x003bb;<sub>3</sub> (Q<sub>&#x003b1;</sub>) 558 (4.27). <sup>1</sup>H NMR (CD<sub>3</sub>CN, 500 MHz): 3.30
(t, 4H, H-22 and H-25); 3.57, 3.59, 3.60, 3.61, 3.70, and 3.71 (6s,
18H, H-17, H-18, H-19, H-20, O&#x02013;CH<sub>3</sub> and O&#x02013;CH<sub>3</sub>); 4.33 (t, 4H, H-21 and H-24); 6.11 (dd, 2H, <italic>J</italic><sub>AB</sub> = 1.52, <italic>J</italic><sub>AX</sub> = 11.51, H<sub>A</sub>); 6.40 (dd, 2H, <italic>J</italic><sub>BA</sub> = 1.49, <italic>J</italic><sub>BX</sub> = 17.82, H<sub>B</sub>); 8.38 (m, 2H, <italic>J</italic><sub>XA</sub> = 11.47, <italic>J</italic><sub>XB</sub> =
17.85, H<sub>X</sub>); 9.94, 10.06, 10.10, 10.17 (4s, 4H, H-&#x003b1;,
H-&#x003b2;, H-&#x003b3; and H-&#x003b4;). <sup>13</sup>C NMR (CD<sub>3</sub>CN, 125 MHz): 11.72, 12.94, 14.32, 22.38, 23.29, 30.83, 32.26, 37.56,
52.06, 99.34, 100.01, 100.21, 100.67, 119.87, 174.46, 207.46 (Ru-CO).
The atoms were numbered according to <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.</p><p><bold>Ru-2</bold>: A pink solid was
obtained from 30.0 mg (0.041
mmol) of <bold>2</bold> and 28.0 mg (0.044 mmol) of [Ru<sub>3</sub>(CO)<sub>12</sub>] in 61% yield (21 mg). The purity observed by HPLC
is &#x0003e;99%. MS (ESI) <italic>m</italic>/<italic>z</italic> (%) 872
[C<sub>37</sub>H<sub>36</sub>N<sub>4</sub>O<sub>5</sub>Ru + 2H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2922, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2859, &#x003bd;&#x02013;Ru&#x02013;C=O
1915, &#x003bd;&#x02013;C=O (ester) 1729. UV&#x02013;vis (DMSO,
&#x003bb;max nm) (log &#x003b5;): &#x003bb;<sub>1</sub> (Soret) 402 (4.76),
&#x003bb;<sub>2</sub> (Q<sub>&#x003b2;</sub>) 524 (4.08), &#x003bb;<sub>3</sub> (Q<sub>&#x003b1;</sub>) 558 (4.11). <sup>1</sup>H NMR (CD<sub>3</sub>CN, 500 MHz): 3.36 (t, 4H, H-22 and H-25); 3.52, 3.55, 3.70,
and 3.71 (4s, 12H, H-17, H-18, H-19 and H-20); 4.34 (t, 4H, H-21 and
H-24); 5.05 (s, 4H, Ph&#x02013;CH<sub>2</sub>); 6.11 (dd, 2H, <italic>J</italic><sub>AB</sub> = 1.72, <italic>J</italic><sub>AX</sub> =
11.54, H<sub>A</sub>); 6.40 (dd, 2H, <italic>J</italic><sub>BA</sub> = 1.78, <italic>J</italic><sub>BX</sub> = 17.89, H<sub>B</sub>);
7.13 (m, 10H, Ph-H); 8.40 (dd, 2H, <italic>J</italic><sub>XA</sub> = 11.75, <italic>J</italic><sub>XB</sub> = 17.58, H<sub>X</sub>);
9.98, 10.04, 10.08, and 10.17 (4s, 4H, H-&#x003b1;, H-&#x003b2;, H-&#x003b3;
and H-&#x003b4;). <sup>13</sup>C NMR (CD<sub>3</sub>CN, 125 MHz): 11.58,
11.79, 18.07, 20.26, 22.52, 29.70, 37.87, 37.93, 66.78, 99.18, 99.36,
99.39, 99.52, 128.58, 128.70, 128.79, 129.29, 129.32, 131.32, 131.42,
136.81, 136.91, 137.47, 138.04, 138.06, 140.02, 140.05, 142.01, 142.34,
142.57, 143.02, 143.05, 143.31, 143.36, 143.91, 144.02, 174.01, 211.04
(Ru-CO). The atoms were numbered according to <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.</p><p><bold>Ru-3A</bold>: A green solid
was obtained from 30.0 mg (0.041
mmol) of <bold>3A</bold> and 29.0 mg (0.045 mmol) of [Ru<sub>3</sub>(CO)<sub>12</sub>] in 13% yield (4 mg). The purity observed by HPLC
is &#x0003e;98%. MS (ESI) <italic>m</italic>/<italic>z</italic> (%) 862
[C<sub>43</sub>H<sub>42</sub>N<sub>4</sub>O<sub>9</sub>Ru + 2H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2992, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2854, &#x003bd;&#x02013;Ru&#x02013;C=O
1927, &#x003bd;&#x02013;C=O (ester) 1722. UV&#x02013;vis (DMSO,
&#x003bb;max nm) (log &#x003b5;): &#x003bb;<sub>1</sub> (Soret) 406 (4.83),
&#x003bb;<sub>2</sub> (Q<sub>&#x003b2;</sub>) 536 (3.81), &#x003bb;<sub>3</sub> (Q<sub>&#x003b1;</sub>) 568 (3.94), &#x003bb;<sub>4</sub> (Q<sub>&#x003b3;</sub>) 606 (4.24). <sup>1</sup>H RMN (acetone-<italic>d</italic><sub>6</sub>, 300 MHz): 2.83 (s, 3H, H-18); 3.14 (t, 2H, H-22); 3.26
(t, 2H, H-25); 3.31 (s, 3H, H-19); 3.55 (s, 3H, H-20); 3.56 (s, 3H,
H-17) 3.57 (dd, 1H, <italic>J</italic> = 2.39, H-28); 3.61 (s, 3H,
O&#x02013;CH<sub>3</sub>); 3.62 (s, 3H, O&#x02013;CH<sub>3</sub>); 3.66
(dd, 1H, <italic>J</italic> = 7.59, H-28); 3.90 (s, 3H, H-31); 4.08
(s, 3H, H-32); 4.11 (t, 2H, H-24); 4.37 (t, 2H, H-21); 6.14 (dd, 1H, <italic>J</italic><sub>AB</sub> = 1.58, <italic>J</italic><sub>AX</sub> =
11.62, H<sub>A</sub>); 6.37 (dd, 1H, <italic>J</italic><sub>BA</sub> = 1.63, <italic>J</italic><sub>BX</sub> = 17.91, H<sub>B</sub>),
7.65 (dd, 1H, <italic>J</italic> = 2.30, H-27), 8.23 (dd, 1H, <italic>J</italic><sub>XA</sub> = 11.67, <italic>J</italic><sub>XB</sub> =
17.88, H<sub>X</sub>), 9.20 (s, 1H, H- &#x003b4;), 9.55 (s, 1H, H-&#x003b1;),
9.77 (s, 1H, H-&#x003b3;), 9.91 (s, 1H, H-&#x003b2;). <sup>13</sup>C NMR
(acetone-<italic>d</italic><sub>6</sub>, 75 MHz): 11.43, 11.50, 12.35,
21.97, 22.17, 37.04, 37.47, 51.69, 51.80, 52.00, 52.79, 91.49, 93.15,
99.95, 100.39, 120.57, 121.95, 127.14, 130.47, 137.91, 141.39, 143.33,
149.10, 149.49, 151.67, 152.00, 152.75, 163.53, 166.63, 173.68, 173.87.
The atoms were numbered according to <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.</p><p><bold>Ru-3B</bold>: A green solid
was obtained from 30.0 mg (0.041
mmol) of <bold>3B</bold> and 29.0 mg (0.045 mmol) of [Ru<sub>3</sub>(CO)<sub>12</sub>] in 16% yield (6 mg). The purity observed by HPLC
is &#x0003e;98%. MS (ESI) <italic>m</italic>/<italic>z</italic> (%) 862
[C<sub>43</sub>H<sub>42</sub>N<sub>4</sub>O<sub>9</sub>Ru + 2H]<sup>+</sup>. IR (ATR, cm<sup>&#x02013;1</sup>): &#x003bd;<sub>as</sub>&#x02013;CH<sub>3</sub> 2923, &#x003bd;<sub>s</sub>&#x02013;CH<sub>3</sub> 2857, &#x003bd;&#x02013;Ru&#x02013;C=O
1923, &#x003bd;&#x02013;C=O (ester) 1721. UV&#x02013;vis (DMSO,
&#x003bb;max nm) (log &#x003b5;): &#x003bb;<sub>1</sub> (Soret) 406 (4.63),
&#x003bb;<sub>2</sub> (Q<sub>&#x003b2;</sub>) 534 (3.66), &#x003bb;<sub>3</sub> (Q<sub>&#x003b1;</sub>) 568 (3.83), &#x003bb;<sub>4</sub> (Q<sub>&#x003b3;</sub>) 606 (4.02). <sup>1</sup>H NMR (acetone-<italic>d</italic><sub>6</sub>, 300 MHz): 2.79 (s, 3H, H-18); 3.17 (t, 2H, H-22); 3.25
(t, 2H, H-25); 3.42 (s, 3H, H-20); 3.54 (s, 3H, H-17); 3.60 (s, 3H,
O&#x02013;CH<sub>3</sub>); 3.61 (s, 3H, O&#x02013;CH<sub>3</sub>); 3.68
(s, 3H, H-19); 3.76 (d, 1H, H-28) 3.88 (s, 3H, H-31); 4.00 (d, 1H,
H-28); 4.03 (s, 3H, H-32); 4.16 (t, 2H); 4.34 (t, 2H); 6.21 (dd, 1H, <italic>J</italic><sub>AB</sub> = 1.447, <italic>J</italic><sub>AX</sub> =
11.586, H<sub>A</sub>); 6.39 (dd, 1H, <italic>J</italic><sub>BA</sub> = 1.466, <italic>J</italic><sub>BX</sub> = 17.892, H<sub>B</sub>); 7.68 (dd; 1H, <sup>3</sup><italic>J</italic> = 6.775, H-27); 8.21
(dd, 1H; <italic>J</italic><sub>XA</sub> = 11.603, <italic>J</italic><sub>XB</sub> = 17.852, H<sub>X</sub>); 9.31 (s, 1H, H-&#x003b1;);
9.55 (s, 1H, H-&#x003b2;); 9.87 (s, 1H, H-&#x003b3;); 9.95 (s, 1H, H-&#x003b4;). <sup>13</sup>C NMR (acetone-<italic>d</italic><sub>6</sub>, 75 MHz): 11.15,
11.49, 12.52, 21.84, 22.14, 36.92, 37.42, 51.69, 51.78, 52.79, 52.92,
55.07, 90.98, 93.37, 99.35, 101.34, 120.89, 121.36, 130.02, 130.36,
137.01, 137.92, 139.05, 139.39, 149.55, 151.84, 152.45, 154.25, 163.23,
166.61, 170.32, 173.63, 173.88. The atoms were numbered according
to <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.</p></sec></sec><sec id="sec4.2.3.2"><title>Crystallography</title><p>Single crystals suitable for X-ray
diffraction were obtained for <bold>3B</bold> and <bold>Ru-1</bold> by slow evaporation of dichloromethane/hexane solution. Data were
collected at room temperature (298 K) on a Bruker Apex-II CCD diffractometer
using monochromatic graphite Mo K&#x003b1; (0.71073&#x001fa;) radiation.
Cell determination and final cell parameters were obtained on all
reflections using the Bruker SAINT software included in the APEX2
software.<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref88">88</xref></sup> The integration and scaling of the data
were carried out using the Bruker SAINT software.<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref88">88</xref></sup> For compound <bold>3B</bold>, weak high-angle diffractions, combined
with the multiple contents and some degree of disorder, caused a large
number of refined parameters with poor data/parameters ratio, which
led to the observed low C&#x02013;C precision. However, the identity
of the structure was clearly established without issue. The CIF files
have been deposited in the Cambridge Structural Data Base under CCDC <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="ccdc" xlink:href="2400652">2400652</ext-link> for <bold>3B</bold> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="ccdc" xlink:href="2400653">2400653</ext-link> for <bold>Ru-1</bold>. Copies of the data can be
obtained, free of charge, at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ccdc.cam.ac.uk">www.ccdc.cam.ac.uk</uri>.</p></sec><sec id="sec4.2.3.3"><title>Stability Studies</title><p>Stability studies were performed
using a Shimadzu 2600 UV&#x02013;vis spectrophotometer at 37 &#x000b0;C
from 1 &#x000d7; 10<sup>&#x02013;5</sup> M solutions of each compound
in pure DMSO or in PBS (Dulbecco&#x02019;s Phosphate Buffered Saline,
Dominique Dutscher SAS without magnesium and calcium) with 0.1% DMSO.
Spectra were recorded every hour for 24 h in DMSO and every hour for
8 h in PBS/DMSO (0.1%).</p></sec><sec id="sec4.2.3.4"><title>Photostability Studies</title><p>The photodegradation
of the
new compounds was evaluated as described in the literature.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Solutions of each compound at a concentration
of 1 &#x000d7; 10<sup>&#x02013;5</sup> M were prepared in pure DMSO or
in PBS/DMSO (0.1%). Each solution was irradiated at 37 &#x000b0;C with
white light (light temperature: 8500 K and light intensity: 50%, SmallRing
brand) at different times until completing 15 min (irradiation time:
0, 3, 6, 9, 12, and 15 min). The absorption spectrum was recorded
after each irradiation.</p></sec><sec id="sec4.2.3.5"><title>EPR Studies</title><p>The detection of singlet
oxygen is based
on the specific reaction between <sup>1</sup>O<sub>2</sub> and 2,2,6,6-tetramethylpiperidine
(TEMP), which produces a stable (2,2,6,6-tetramethylpiperidin-1-yl)oxyl
(TEMPO) radical adduct. Detection of <sup>1</sup>O<sub>2</sub> was
carried out according to the following procedure. Solutions of 1 &#x000d7;
10<sup>&#x02013;3</sup> M of the compounds and 0.06 M TEMP in ethanol/DMSO
(1%, final volume 400 &#x003bc;L) equilibrated with air at room temperature
were irradiated with visible light in a flat cell for up to 15 min,
generating the characteristic triplet signal corresponding to TEMPO.
EPR spectra were obtained with the following parameters: center field,
334.5 &#x000b1; 4 mT; power, 1.0 mW; microwave frequency, 9.43 GHz; modulation
width, 0.5 mT; time constant, 0.1 s; amplitude, 10. The oxygen concentration
was measured using an Iuzmar dissolved oxygen meter. For the detection
of superoxide radical (O<sub>2</sub><sup>&#x02022;&#x02013;</sup>),
5,5-dimethyl-1-pyrroline-<italic>N</italic>-oxide (DMPO, from Dojindo
Japan) was used. Detection of O<sub>2</sub><sup>&#x02022;&#x02013;</sup> was carried out according to the following procedure. A mixture
of 1 &#x000d7; 10<sup>&#x02013;3</sup> M solution of the compounds and
a 0.07 M solution of DMPO in methanol/DMSO (1%, final volume 400 &#x003bc;L)
at room temperature were irradiated with visible light in a flat cell
for up to 15 min, generating the signal of the DMPO-O<sub>2</sub><sup>&#x02022;&#x02013;</sup> adduct. EPR spectra were obtained with the
following parameters: center field, 335 &#x000b1; 4 mT; power, 8.0 mW;
microwave frequency, 9.43 GHz; modulation width, 0.63 mT; time constant,
0.1 s; amplitude, 100.</p></sec><sec id="sec4.2.3.6"><title>Fluorescence Quantum Yield Measurements</title><p>The fluorescence
quantum yields were determined using verteporfin in DMSO as a reference
(&#x003a6;<sub>f</sub> = 0.0085).<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref89">89</xref></sup> The free ligands were
excited at 503 nm, and the ruthenium complexes at 573 nm. The quantum
yield was calculated following <xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>.<sup><xref ref-type="bibr" rid="ref90">90</xref>,<xref ref-type="bibr" rid="ref91">91</xref></sup><disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_m001" position="anchor"/><label>1</label></disp-formula>Where ST and <italic>X</italic> are standard
and analyte, respectively, &#x003a6;<sub>f</sub> is the fluorescence
quantum yield, Grad is the gradient from the area of integration fluorescence
intensity <italic>vs</italic> absorbance, and &#x003b7;<sub><italic>X</italic></sub> and &#x003b7;<sub>ST</sub> are the refractive index
of the solvent used to measure the fluorescence spectrum of the analyte
and the standard, respectively.</p></sec><sec id="sec4.2.3.7"><title>Oxygen Singlet Quantum
Yield Measurements</title><p>Quantum yields
of singlet oxygen (<sup>1</sup>O<sub>2</sub>) production were determined
in DMSO equilibrated with oxygen and white light, using verteporfin
as a reference and 1,3-diphenylisobenzofuran (DPBF) as a chemical
trap which in the presence of singlet oxygen is oxidized to 1,2-dibenzoylbenzene.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> The absorption band of DPBF was monitored at
214 nm.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> The <sup>1</sup>O<sub>2</sub> production quantum yields of the compounds were determined following <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula">2</xref></xref>.<sup><xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref95">95</xref></sup><disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_m002" position="anchor"/><label>2</label></disp-formula>Where PS is the photosensitizer, &#x003a6;<sub>&#x00394;ref</sub> is
singlet oxygen production quantum yield of verteporfin
(&#x003a6;<sub>&#x00394;</sub> = 0.77 in DMSO<sup><xref ref-type="bibr" rid="ref46">46</xref></sup>) and <italic>k</italic><sub>ref</sub> and <italic>k</italic><sub>PS</sub> are the decay constant of DPBF in the presence of the standard
(VP) or each PS and are obtained from the slope obtained from the
absorbance of DPBF at different irradiation times.</p></sec><sec id="sec4.2.3.8"><title>Lipophilicity
Studies</title><p>The partition coefficient (log&#x0202f;<italic>P</italic><sub>o/PBS</sub>) of each compound was determined experimentally
by the &#x0201c;<italic>shake-flask</italic>&#x0201d; method at room
temperature following reported methods.<sup><xref ref-type="bibr" rid="ref57">57</xref>,<xref ref-type="bibr" rid="ref96">96</xref></sup> A mixture
of 1-octanol and PBS in equal amounts was shaken for 24 h, after which
the phases were allowed to separate for 24 h. Then, a 1 &#x000d7; 10<sup>&#x02013;5</sup> M solution of each compound is prepared in 1-octanol/PBS
(1:1), and the mixture is left to stir for 24 h. After 24 h of stirring,
the mixture is left for 24 h to separate the two phases. Finally,
the concentration of each compound in the two phases is determined
by UV&#x02013;vis spectroscopy. log<italic>P</italic> was determined
by the following <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>.<sup><xref ref-type="bibr" rid="ref97">97</xref></sup><disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_m003" position="anchor"/><label>3</label></disp-formula>Where <italic>A</italic><sub>ap</sub> is the
absorbance after partition, and <italic>A</italic><sub>bp</sub> is
the absorbance before partition.</p></sec></sec><sec id="sec4.3"><title>Biology</title><sec id="sec4.3.1"><title>Cell Lines</title><p>The human gastric adenocarcinoma (AGS) cell
line was acquired from ATCC (Manassa, VA). AGS cells were cultured
in RPMI 1640 medium (Roswell Park Memorial Institute) containing 10%
fetal bovine serum (FBS) at 37 &#x000b0;C in a humidified atmosphere
of 95% air and 5% CO<sub>2</sub>.</p></sec><sec id="sec4.3.2"><title>MTT Survival Assays</title><p>The antiproliferative activity
of cancer cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. Cells were seeded at 10.000 cells per well (200
&#x003bc;L) in Cellstar 96-well plates (Greiner Bio-One) and further
incubated for 24 h. Cells were treated with each compound at different
concentrations for 8 h in the dark. After this time, the medium was
removed, fresh medium was added, and cells were kept in the dark or
irradiated with white light for 15 min. Subsequently, the plates were
incubated in the dark for an additional 48 h, and the MTT assay was
performed as previously described in the literature.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Measurements were performed at 550 nm with the Tristar2Multimode
Reader (Berthold Technologies).</p></sec><sec id="sec4.3.3"><title>Western Blotting<sup><xref ref-type="bibr" rid="ref98">98</xref></sup></title><p>AGS cells
were treated with the IC<sub>50</sub> of each compound for 4 h at
37 &#x000b0;C in the dark and then were either kept in the dark or irradiated
with white light for 15 min and further cultivated in the dark for
an additional 24 h. Cells were then lysed in lysis buffer (50&#x0202f;mM
Tris&#x02013;HCl pH&#x0202f;6.7, NaCl 150&#x0202f;mM, NP40 1%). Total
protein concentration was determined using Bradford assay and adjusted
to the same quantity (50 &#x003bc;g) for each experiment. A total of
30 &#x003bc;g of proteins were resolved by 6&#x02013;15% SDS-PAGE (depending
on protein molecular weight) and transferred to nitrocellulose blotting
membranes according to standard methods. Membranes were blocked with
blocking buffer (containing 5% milk powder or 1% BSA) for 1 h at room
temperature, then washed three times with TBST or PBST (containing
0.1% Tween-20) and incubated with primary antibodies at 4 &#x000b0;C
overnight. The following day, the membranes were washed thrice with
PBST or PBST. The membranes were incubated with antirabbit or antimouse
antibodies for 1 h at room temperature and visualized by enhanced
chemiluminescence using the ClarityTM ECL Western Blotting Substrate
Bio-Rad reagent according to the manufacturer&#x02019;s instructions.
Signals were acquired with the help of Immobilon Crescendo or Ozyme
on Syngene PX<italic>i</italic> equipment using GeneSys software.
Protein bands were quantified using ImageJ software.<sup><xref ref-type="bibr" rid="ref99">99</xref></sup> Western blots were performed using the following antibodies:
GAPDH (6C5) (1:2000, sc-32233, Santa Cruz Biotechnology); Cleaved
PARP (D64E10) (1:1000, 5625S, Cell Signaling Technology); COX2 (D5H5)
(1:1000, 12282S, Cell Signaling Technology); CHOP/GADD 153 (B-3) (1:500,
sc-7351, Santa Cruz Biotechnology); Cleaved Caspase-3 (D175) (1:1000,
9661L, Cell Signaling Technology); GPX4 (1:1000, ab25066, abcan) and
LC3B (D11) (1:1000, 3868S, Cell Signaling Technology). The secondary
antibodies were: Antirabbit IgG (1:10000, 7074S, Cell Signaling Technology)
and Anti-Mouse IgG (1:8000, 7076S, Cell Signaling Technology). Loading
was controlled by glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
for normalization.</p></sec></sec></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.inorgchem.5c00896?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.inorgchem.5c00896</ext-link>.<list id="silist" list-type="simple"><list-item><p>Mass spectra;
IR spectra; NMR spectra; UV&#x02013;vis
spectra; EPR spectra and cell survival graphs (Figures S1&#x02013;S102);
crystallographic data and quantum yields (Tables S1 and S2) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.inorgchem.5c00896/suppl_file/ic5c00896_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ic5c00896_si_001.pdf"><caption><p>ic5c00896_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes-4"><title>Author Present Address</title><p><sup>&#x02225;</sup> INSERM,
UMR_S1260, Regenerative Nanomedicine; Team GP-SMIT; CRBS,
1 Rue Eug&#x000e8;ne Boeckel, 67085 Strasbourg, France</p></notes><notes notes-type="" id="notes-5"><title>Author Present Address</title><p><sup>&#x022a5;</sup> UMR7242, Biotechnology et Signalisation Cellulaire, 300 Boulevard
S. Brant, 67412 Illkirch Cedex, France</p></notes><notes notes-type="" id="notes-2"><title>Author Contributions</title><p>The manuscript
was written with contributions from all authors. All authors have
approved the final version of the manuscript.</p></notes><notes notes-type="COI-statement" id="notes-3"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We wish
to thank the financial support from DGAPA-UNAM (PAPIIT
projects IN-211522 and IN207725), Consejo Nacional de Ciencia y Tecnolog&#x000ed;a
(Project A1-S-15068 and grant 996154 to A. Restrepo-Acevedo), ECOS
Nord (Project 279063), and the Long Duration National or International
Academic Activities program from the General Coordination of Graduate
Studies at UNAM. We thank M. P. Orta Perez, A. Romo, L. del Carmen
M&#x000e1;rquez, E. Garc&#x000ed;a R&#x000ed;os, L. Rios Ruiz, J. D.
V&#x000e1;zquez Cuevas, M. M. Aguilar Araiza, G. E. Cort&#x000e9;s Romero,
and N. Perrusson for obtaining analytical data and for technical assistance.
Rub&#x000e9;n A. Toscano is thanked for X-ray diffraction crystallographic
studies.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Oluwajembola</surname><given-names>A. M.</given-names></name>; <name><surname>Cleanclay</surname><given-names>W. D.</given-names></name>; <name><surname>Onyia</surname><given-names>A. F.</given-names></name>; <name><surname>Chikere</surname><given-names>B. N.</given-names></name>; <name><surname>Zakari</surname><given-names>S.</given-names></name>; <name><surname>Ndifreke</surname><given-names>E.</given-names></name>; <name><surname>De Campos</surname><given-names>O. C.</given-names></name>
<article-title>Photosensitizers in photodynamic
therapy: An advancement in cancer treatment</article-title>. <source>Results Chem.</source>
<year>2024</year>, <volume>10</volume>, <elocation-id>101715</elocation-id><pub-id pub-id-type="doi">10.1016/j.rechem.2024.101715</pub-id>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Doan</surname><given-names>B. T.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Metal-Based Photosensitizers
as Inducers
of Regulated Cell Death Mechanisms</article-title>. <source>Chem. Rev.</source>
<year>2023</year>, <volume>123</volume> (<issue>16</issue>), <fpage>10135</fpage>&#x02013;<lpage>10155</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.3c00161</pub-id>.<pub-id pub-id-type="pmid">37534710</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Alderden</surname><given-names>R. A.</given-names></name>; <name><surname>Hall</surname><given-names>M. D.</given-names></name>; <name><surname>Hambley</surname><given-names>T. W.</given-names></name>
<article-title>The Discovery and Development of
Cisplatin</article-title>. <source>J. Chem. Educ.</source>
<year>2006</year>, <volume>83</volume> (<issue>5</issue>), <elocation-id>728</elocation-id><pub-id pub-id-type="doi">10.1021/ed083p728</pub-id>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Johnstone</surname><given-names>T. C.</given-names></name>; <name><surname>Suntharalingam</surname><given-names>K.</given-names></name>; <name><surname>Lippard</surname><given-names>S. J.</given-names></name>
<article-title>The Next Generation of Platinum Drugs:
Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs</article-title>. <source>Chem. Rev.</source>
<year>2016</year>, <volume>116</volume> (<issue>5</issue>), <fpage>3436</fpage>&#x02013;<lpage>3486</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.5b00597</pub-id>.<pub-id pub-id-type="pmid">26865551</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Kelland</surname><given-names>L.</given-names></name>
<article-title>The resurgence
of platinum-based cancer chemotherapy</article-title>. <source>Nat.
Rev. Cancer</source>
<year>2007</year>, <volume>7</volume> (<issue>8</issue>), <fpage>573</fpage>&#x02013;<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2167</pub-id>.<pub-id pub-id-type="pmid">17625587</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Florea</surname><given-names>A.-M.</given-names></name>; <name><surname>B&#x000fc;sselberg</surname><given-names>D.</given-names></name>
<article-title>Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms
of Activity, Drug Resistance and Induced Side Effects</article-title>. <source>Cancers</source>
<year>2011</year>, <volume>3</volume> (<issue>1</issue>), <fpage>1351</fpage>&#x02013;<lpage>1371</lpage>. <pub-id pub-id-type="doi">10.3390/cancers3011351</pub-id>.<pub-id pub-id-type="pmid">24212665</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Klein</surname><given-names>A. V.</given-names></name>; <name><surname>Hambley</surname><given-names>T. W.</given-names></name>
<article-title>Platinum Drug Distribution
in Cancer Cells and Tumors</article-title>. <source>Chem. Rev.</source>
<year>2009</year>, <volume>109</volume> (<issue>10</issue>), <fpage>4911</fpage>&#x02013;<lpage>4920</lpage>. <pub-id pub-id-type="doi">10.1021/cr9001066</pub-id>.<pub-id pub-id-type="pmid">19711978</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Aebisher</surname><given-names>D.</given-names></name>; <name><surname>Serafin</surname><given-names>I.</given-names></name>; <name><surname>Bat&#x000f3;g-Szcz&#x00065;&#x00328;ch</surname><given-names>K.</given-names></name>; <name><surname>Dynarowicz</surname><given-names>K.</given-names></name>; <name><surname>Chodurek</surname><given-names>E.</given-names></name>; <name><surname>Kawczyk-Krupka</surname><given-names>A.</given-names></name>; <name><surname>Bartusik-Aebisher</surname><given-names>D.</given-names></name>
<article-title>Photodynamic Therapy in the Treatment of Cancer&#x02014;The
Selection of Synthetic Photosensitizers</article-title>. <source>Pharmaceuticals</source>
<year>2024</year>, <volume>17</volume> (<issue>7</issue>), <elocation-id>932</elocation-id><pub-id pub-id-type="doi">10.3390/ph17070932</pub-id>.<pub-id pub-id-type="pmid">39065781</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Doan</surname><given-names>B.-T.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Metal-Based
Photosensitizers as Inducers
of Regulated Cell Death Mechanisms</article-title>. <source>Chem. Rev.</source>
<year>2023</year>, <volume>123</volume> (<issue>16</issue>), <fpage>10135</fpage>&#x02013;<lpage>10155</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.3c00161</pub-id>.<pub-id pub-id-type="pmid">37534710</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Yin</surname><given-names>H.</given-names></name>; <name><surname>Stephenson</surname><given-names>M.</given-names></name>; <name><surname>Gibson</surname><given-names>J.</given-names></name>; <name><surname>Sampson</surname><given-names>E.</given-names></name>; <name><surname>Shi</surname><given-names>G.</given-names></name>; <name><surname>Sainuddin</surname><given-names>T.</given-names></name>; <name><surname>Monro</surname><given-names>S.</given-names></name>; <name><surname>McFarland</surname><given-names>S. A.</given-names></name>
<article-title>In Vitro
Multiwavelength PDT with 3IL States: Teaching Old Molecules New Tricks</article-title>. <source>Inorg. Chem.</source>
<year>2014</year>, <volume>53</volume> (<issue>9</issue>), <fpage>4548</fpage>&#x02013;<lpage>4559</lpage>. <pub-id pub-id-type="doi">10.1021/ic5002368</pub-id>.<pub-id pub-id-type="pmid">24725142</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Gunaydin</surname><given-names>G.</given-names></name>; <name><surname>Gedik</surname><given-names>M. E.</given-names></name>; <name><surname>Ayan</surname><given-names>S.</given-names></name>
<article-title>Photodynamic
Therapy-Current Limitations
and Novel Approaches</article-title>. <source>Front. Chem.</source>
<year>2021</year>, <volume>9</volume>, <elocation-id>691697</elocation-id><pub-id pub-id-type="doi">10.3389/fchem.2021.691697</pub-id>.<pub-id pub-id-type="pmid">34178948</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Correia</surname><given-names>J. H.</given-names></name>; <name><surname>Rodrigues</surname><given-names>J. A.</given-names></name>; <name><surname>Pimenta</surname><given-names>S.</given-names></name>; <name><surname>Dong</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>
<article-title>Photodynamic
Therapy Review: Principles, Photosensitizers, Applications, and Future
Directions</article-title>. <source>Pharmaceutics</source>
<year>2021</year>, <volume>13</volume> (<issue>9</issue>), <elocation-id>1332</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13091332</pub-id>.<pub-id pub-id-type="pmid">34575408</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>He</surname><given-names>W.</given-names></name>; <name><surname>Guo</surname><given-names>Z.</given-names></name>
<article-title>Recent advances in
noble metal complex based photodynamic therapy</article-title>. <source>Chem. Sci.</source>
<year>2022</year>, <volume>13</volume> (<issue>18</issue>), <fpage>5085</fpage>&#x02013;<lpage>5106</lpage>. <pub-id pub-id-type="doi">10.1039/D1SC05478C</pub-id>.<pub-id pub-id-type="pmid">35655575</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Juarranz</surname><given-names>&#x000c1;.</given-names></name>; <name><surname>Ja&#x000e9;n</surname><given-names>P.</given-names></name>; <name><surname>Sanz-Rodr&#x000ed;guez</surname><given-names>F.</given-names></name>; <name><surname>Cuevas</surname><given-names>J.</given-names></name>; <name><surname>Gonz&#x000e1;lez</surname><given-names>S.</given-names></name>
<article-title>Photodynamic therapy of cancer. Basic principles and
applications</article-title>. <source>Clin. Transl. Oncol.</source>
<year>2008</year>, <volume>10</volume> (<issue>3</issue>), <fpage>148</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1007/s12094-008-0172-2</pub-id>.<pub-id pub-id-type="pmid">18321817</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Sim&#x000f5;es</surname><given-names>J. C. S.</given-names></name>; <name><surname>Sarpaki</surname><given-names>S.</given-names></name>; <name><surname>Papadimitroulas</surname><given-names>P.</given-names></name>; <name><surname>Therrien</surname><given-names>B.</given-names></name>; <name><surname>Loudos</surname><given-names>G.</given-names></name>
<article-title>Conjugated
Photosensitizers for Imaging and PDT in Cancer Research</article-title>. <source>J. Med. Chem.</source>
<year>2020</year>, <volume>63</volume> (<issue>23</issue>), <fpage>14119</fpage>&#x02013;<lpage>14150</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c00047</pub-id>.<pub-id pub-id-type="pmid">32990442</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Sun</surname><given-names>B.</given-names></name>; <name><surname>Bte Rahmat</surname><given-names>J. N.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>
<article-title>Advanced techniques for performing
photodynamic therapy in deep-seated tissues</article-title>. <source>Biomaterials</source>
<year>2022</year>, <volume>291</volume>, <elocation-id>121875</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121875</pub-id>.<pub-id pub-id-type="pmid">36335717</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Yoon</surname><given-names>I.</given-names></name>; <name><surname>Li</surname><given-names>J. Z.</given-names></name>; <name><surname>Shim</surname><given-names>Y. K.</given-names></name>
<article-title>Advance
in photosensitizers and light
delivery for photodynamic therapy</article-title>. <source>Clinical
Endoscopy</source>
<year>2013</year>, <volume>46</volume> (<issue>1</issue>), <fpage>7</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.5946/ce.2013.46.1.7</pub-id>.<pub-id pub-id-type="pmid">23423543</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>D&#x00105;browski</surname><given-names>J. M.</given-names></name>; <name><surname>Pucelik</surname><given-names>B.</given-names></name>; <name><surname>Regiel-Futyra</surname><given-names>A.</given-names></name>; <name><surname>Brindell</surname><given-names>M.</given-names></name>; <name><surname>Mazuryk</surname><given-names>O.</given-names></name>; <name><surname>Kyzio&#x00142;</surname><given-names>A.</given-names></name>; <name><surname>Stochel</surname><given-names>G.</given-names></name>; <name><surname>Macyk</surname><given-names>W.</given-names></name>; <name><surname>Arnaut</surname><given-names>L. G.</given-names></name>
<article-title>Engineering
of relevant photodynamic processes through structural modifications
of metallotetrapyrrolic photosensitizers</article-title>. <source>Coord.
Chem. Rev.</source>
<year>2016</year>, <volume>325</volume>, <fpage>67</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2016.06.007</pub-id>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Otvagin</surname><given-names>V. F.</given-names></name>; <name><surname>Kuzmina</surname><given-names>N. S.</given-names></name>; <name><surname>Kudriashova</surname><given-names>E. S.</given-names></name>; <name><surname>Nyuchev</surname><given-names>A. V.</given-names></name>; <name><surname>Gavryushin</surname><given-names>A. E.</given-names></name>; <name><surname>Fedorov</surname><given-names>A. Y.</given-names></name>
<article-title>Conjugates of Porphyrinoid-Based Photosensitizers with
Cytotoxic Drugs: Current Progress and Future Directions toward Selective
Photodynamic Therapy</article-title>. <source>J. Med. Chem.</source>
<year>2022</year>, <volume>65</volume> (<issue>3</issue>), <fpage>1695</fpage>&#x02013;<lpage>1734</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.1c01953</pub-id>.<pub-id pub-id-type="pmid">35050607</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Xue</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Jiao</surname><given-names>J.</given-names></name>; <name><surname>Qin</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>
<article-title>Photodynamic
therapy for prostate cancer: Recent advances, challenges and opportunities</article-title>. <source>Front. Oncol.</source>
<year>2022</year>, <volume>12</volume>, <elocation-id>980239</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.980239</pub-id>.<pub-id pub-id-type="pmid">36212416</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Mukherjee</surname><given-names>R.</given-names></name>
<article-title>A Comprehensive
Review for Ruthenium(II) Complexes in Photodynamic Therapy</article-title>. <source>Asian J. Chem.</source>
<year>2023</year>, <volume>35</volume> (<issue>11</issue>), <fpage>2595</fpage>&#x02013;<lpage>2602</lpage>. <pub-id pub-id-type="doi">10.14233/ajchem.2023.28555</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Pozza</surname><given-names>M. D.</given-names></name>; <name><surname>Mesdom</surname><given-names>P.</given-names></name>; <name><surname>Abdullrahman</surname><given-names>A.</given-names></name>; <name><surname>Otoya</surname><given-names>T. D. P.</given-names></name>; <name><surname>Arnoux</surname><given-names>P.</given-names></name>; <name><surname>Frochot</surname><given-names>C.</given-names></name>; <name><surname>Niogret</surname><given-names>G.</given-names></name>; <name><surname>Saubamea</surname><given-names>B.</given-names></name>; <name><surname>Burckel</surname><given-names>P.</given-names></name>; <name><surname>Hall</surname><given-names>J. P.</given-names></name>; <name><surname>Hollenstein</surname><given-names>M.</given-names></name>; <name><surname>Cardin</surname><given-names>C. J.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Increasing
the pi-Expansive Ligands in Ruthenium(II) Polypyridyl Complexes: Synthesis,
Characterization, and Biological Evaluation for Photodynamic Therapy
Applications</article-title>. <source>Inorg. Chem.</source>
<year>2023</year>, <volume>62</volume> (<issue>45</issue>), <fpage>18510</fpage>&#x02013;<lpage>18523</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c02606</pub-id>.<pub-id pub-id-type="pmid">37913550</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Monro</surname><given-names>S.</given-names></name>; <name><surname>Colon</surname><given-names>K. L.</given-names></name>; <name><surname>Yin</surname><given-names>H.</given-names></name>; <name><surname>Roque</surname><given-names>J.</given-names><suffix>3rd</suffix></name>; <name><surname>Konda</surname><given-names>P.</given-names></name>; <name><surname>Gujar</surname><given-names>S.</given-names></name>; <name><surname>Thummel</surname><given-names>R. P.</given-names></name>; <name><surname>Lilge</surname><given-names>L.</given-names></name>; <name><surname>Cameron</surname><given-names>C. G.</given-names></name>; <name><surname>McFarland</surname><given-names>S. A.</given-names></name>
<article-title>Transition
Metal Complexes and Photodynamic
Therapy from a Tumor-Centered Approach: Challenges, Opportunities,
and Highlights from the Development of TLD1433</article-title>. <source>Chem. Rev.</source>
<year>2019</year>, <volume>119</volume> (<issue>2</issue>), <fpage>797</fpage>&#x02013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00211</pub-id>.<pub-id pub-id-type="pmid">30295467</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Gianferrara</surname><given-names>T.</given-names></name>; <name><surname>Bergamo</surname><given-names>A.</given-names></name>; <name><surname>Bratsos</surname><given-names>I.</given-names></name>; <name><surname>Milani</surname><given-names>B.</given-names></name>; <name><surname>Spagnul</surname><given-names>C.</given-names></name>; <name><surname>Sava</surname><given-names>G.</given-names></name>; <name><surname>Alessio</surname><given-names>E.</given-names></name>
<article-title>Ruthenium&#x02013;Porphyrin
Conjugates
with Cytotoxic and Phototoxic Antitumor Activity</article-title>. <source>J. Med. Chem.</source>
<year>2010</year>, <volume>53</volume> (<issue>12</issue>), <fpage>4678</fpage>&#x02013;<lpage>4690</lpage>. <pub-id pub-id-type="doi">10.1021/jm1002588</pub-id>.<pub-id pub-id-type="pmid">20491441</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Vizzotto</surname><given-names>B. S.</given-names></name>; <name><surname>Dias</surname><given-names>R. S.</given-names></name>; <name><surname>Iglesias</surname><given-names>B. A.</given-names></name>; <name><surname>Krause</surname><given-names>L. F.</given-names></name>; <name><surname>Viana</surname><given-names>A. R.</given-names></name>; <name><surname>Schuch</surname><given-names>A. P.</given-names></name>
<article-title>DNA photocleavage
and melanoma cells cytotoxicity induced
by a meso-tetra-ruthenated porphyrin under visible light irradiation</article-title>. <source>J. Photochem. Photobiol., B</source>
<year>2020</year>, <volume>209</volume>, <elocation-id>111922</elocation-id><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2020.111922</pub-id>.<pub-id pub-id-type="pmid">32526689</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Ge</surname><given-names>J.</given-names></name>; <name><surname>Lan</surname><given-names>M.</given-names></name>; <name><surname>Zhou</surname><given-names>B.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Guo</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Jia</surname><given-names>Q.</given-names></name>; <name><surname>Niu</surname><given-names>G.</given-names></name>; <name><surname>Huang</surname><given-names>X.</given-names></name>; <name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>Meng</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>P.</given-names></name>; <name><surname>Lee</surname><given-names>C.-S.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Han</surname><given-names>X.</given-names></name>
<article-title>A graphene
quantum dot photodynamic therapy agent with high singlet oxygen generation</article-title>. <source>Nat. Commun.</source>
<year>2014</year>, <volume>5</volume> (<issue>1</issue>), <elocation-id>4596</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5596</pub-id>.<pub-id pub-id-type="pmid">25105845</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="book" id="cit27"><person-group person-group-type="allauthors"><name><surname>Amselem</surname><given-names>L.</given-names></name>; <name><surname>Mon&#x000e9;s</surname><given-names>J. M.</given-names></name>; <name><surname>Arias</surname><given-names>L.</given-names></name></person-group><article-title>Photosensitizers
and Photodynamic Therapy: Verteporfin</article-title>. In <source>Retinal Pharmacotherapy</source>; <person-group person-group-type="editor"><name><surname>Nguyen</surname><given-names>Q. D.</given-names></name>; <name><surname>Rodrigues</surname><given-names>E. B.</given-names></name>; <name><surname>Farah</surname><given-names>M. E.</given-names></name>; <name><surname>Mieler</surname><given-names>W. F.</given-names></name></person-group>, Eds.; <publisher-name>W.B.
Saunders</publisher-name>, <year>2010</year>; Chapter 43, pp <fpage>297</fpage>&#x02013;<lpage>305</lpage>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Gibault</surname><given-names>F.</given-names></name>; <name><surname>Bailly</surname><given-names>F.</given-names></name>; <name><surname>Corvaisier</surname><given-names>M.</given-names></name>; <name><surname>Coevoet</surname><given-names>M.</given-names></name>; <name><surname>Huet</surname><given-names>G.</given-names></name>; <name><surname>Melnyk</surname><given-names>P.</given-names></name>; <name><surname>Cotelle</surname><given-names>P.</given-names></name>
<article-title>Molecular Features of the YAP Inhibitor
Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors
of YAP/TAZ, the Downstream Effectors of the Hippo Pathway</article-title>. <source>ChemMedChem</source>
<year>2017</year>, <volume>12</volume> (<issue>12</issue>), <fpage>954</fpage>&#x02013;<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201700063</pub-id>.<pub-id pub-id-type="pmid">28334506</pub-id>
</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Houle</surname><given-names>J. M.</given-names></name>; <name><surname>Strong</surname><given-names>H. A.</given-names></name>
<article-title>Duration of skin
photosensitivity and incidence of
photosensitivity reactions after administration of verteporfin</article-title>. <source>Retina</source>
<year>2002</year>, <volume>22</volume> (<issue>6</issue>), <fpage>691</fpage>&#x02013;<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1097/00006982-200212000-00002</pub-id>.<pub-id pub-id-type="pmid">12476093</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Sung</surname><given-names>H.</given-names></name>; <name><surname>Ferlay</surname><given-names>J.</given-names></name>; <name><surname>Siegel</surname><given-names>R. L.</given-names></name>; <name><surname>Laversanne</surname><given-names>M.</given-names></name>; <name><surname>Soerjomataram</surname><given-names>I.</given-names></name>; <name><surname>Jemal</surname><given-names>A.</given-names></name>; <name><surname>Bray</surname><given-names>F.</given-names></name>
<article-title>Global Cancer
Statistics
2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for
36 Cancers in 185 Countries</article-title>. <source>Ca-Cancer J. Clin.</source>
<year>2021</year>, <volume>71</volume> (<issue>3</issue>), <fpage>209</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>.<pub-id pub-id-type="pmid">33538338</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Mihmanli</surname><given-names>M.</given-names></name>; <name><surname>Ilhan</surname><given-names>E.</given-names></name>; <name><surname>Idiz</surname><given-names>U. O.</given-names></name>; <name><surname>Alemdar</surname><given-names>A.</given-names></name>; <name><surname>Demir</surname><given-names>U.</given-names></name>
<article-title>Recent developments
and innovations in gastric cancer</article-title>. <source>World J.
Gastroenterol.</source>
<year>2016</year>, <volume>22</volume> (<issue>17</issue>), <fpage>4307</fpage>&#x02013;<lpage>4320</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v22.i17.4307</pub-id>.<pub-id pub-id-type="pmid">27158199</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Han</surname><given-names>K. H.</given-names></name>; <name><surname>Choi</surname><given-names>Y. J.</given-names></name>; <name><surname>Il Kim</surname><given-names>T.</given-names></name>; <name><surname>Park</surname><given-names>N. H.</given-names></name>; <name><surname>Han</surname><given-names>K.-d.</given-names></name>; <name><surname>Lee</surname><given-names>D. H.</given-names></name>
<article-title>Association between
glycemic status and the risk of
gastric cancer in pre/peri-and postmenopausal women: A nationwide
cohort study</article-title>. <source>Ann. Epidemiol.</source>
<year>2024</year>, <volume>94</volume>, <fpage>106</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2024.04.009</pub-id>.<pub-id pub-id-type="pmid">38663524</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Shu</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Jia</surname><given-names>B.</given-names></name>; <name><surname>Song</surname><given-names>M.</given-names></name>
<article-title>Cellular and Molecular
Mechanisms of Chemoresistance for Gastric
Cancer</article-title>. <source>Int. J. Gen. Med.</source>
<year>2024</year>, <volume>17</volume>, <fpage>3779</fpage>&#x02013;<lpage>3788</lpage>. <pub-id pub-id-type="doi">10.2147/IJGM.S473749</pub-id>.<pub-id pub-id-type="pmid">39224691</pub-id>
</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Blanchet</surname><given-names>A.</given-names></name>; <name><surname>Bourgmayer</surname><given-names>A.</given-names></name>; <name><surname>Kurtz</surname><given-names>J.-E.</given-names></name>; <name><surname>Mellitzer</surname><given-names>G.</given-names></name>; <name><surname>Gaiddon</surname><given-names>C.</given-names></name>
<article-title>Isoforms of the p53
Family and Gastric Cancer: A M&#x000e9;nage
&#x000e0; Trois for an Unfinished Affair</article-title>. <source>Cancers</source>
<year>2021</year>, <volume>13</volume> (<issue>4</issue>), <elocation-id>916</elocation-id><pub-id pub-id-type="doi">10.3390/cancers13040916</pub-id>.<pub-id pub-id-type="pmid">33671606</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Vidimar</surname><given-names>V.</given-names></name>; <name><surname>Meng</surname><given-names>X.</given-names></name>; <name><surname>Klajner</surname><given-names>M.</given-names></name>; <name><surname>Licona</surname><given-names>C.</given-names></name>; <name><surname>Fetzer</surname><given-names>L.</given-names></name>; <name><surname>Harlepp</surname><given-names>S.</given-names></name>; <name><surname>Hebraud</surname><given-names>P.</given-names></name>; <name><surname>Sidhoum</surname><given-names>M.</given-names></name>; <name><surname>Sirlin</surname><given-names>C.</given-names></name>; <name><surname>Loeffler</surname><given-names>J. P.</given-names></name>; <name><surname>Mellitzer</surname><given-names>G.</given-names></name>; <name><surname>Sava</surname><given-names>G.</given-names></name>; <name><surname>Pfeffer</surname><given-names>M.</given-names></name>; <name><surname>Gaiddon</surname><given-names>C.</given-names></name>
<article-title>Induction of caspase 8 and reactive oxygen species
by ruthenium-derived anticancer compounds with improved water solubility
and cytotoxicity</article-title>. <source>Biochem. Pharmacol.</source>
<year>2012</year>, <volume>84</volume> (<issue>11</issue>), <fpage>1428</fpage>&#x02013;<lpage>1436</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2012.08.022</pub-id>.<pub-id pub-id-type="pmid">22964219</pub-id>
</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Vidimar</surname><given-names>V.</given-names></name>; <name><surname>Licona</surname><given-names>C.</given-names></name>; <name><surname>Cer&#x000f3;n-Camacho</surname><given-names>R.</given-names></name>; <name><surname>Guerin</surname><given-names>E.</given-names></name>; <name><surname>Coliat</surname><given-names>P.</given-names></name>; <name><surname>Venkatasamy</surname><given-names>A.</given-names></name>; <name><surname>Ali</surname><given-names>M.</given-names></name>; <name><surname>Guenot</surname><given-names>D.</given-names></name>; <name><surname>Le Lagadec</surname><given-names>R.</given-names></name>; <name><surname>Jung</surname><given-names>A. C.</given-names></name>; <name><surname>Freund</surname><given-names>J.-N.</given-names></name>; <name><surname>Pfeffer</surname><given-names>M.</given-names></name>; <name><surname>Mellitzer</surname><given-names>G.</given-names></name>; <name><surname>Sava</surname><given-names>G.</given-names></name>; <name><surname>Gaiddon</surname><given-names>C.</given-names></name>
<article-title>A redox ruthenium compound
directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor
angiogenesis independently of p53</article-title>. <source>Cancer Lett.</source>
<year>2019</year>, <volume>440&#x02013;441</volume>, <fpage>145</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2018.09.029</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Riegel</surname><given-names>G.</given-names></name>; <name><surname>Orvain</surname><given-names>C.</given-names></name>; <name><surname>Recberlik</surname><given-names>S.</given-names></name>; <name><surname>Spaety</surname><given-names>M. E.</given-names></name>; <name><surname>Poschet</surname><given-names>G.</given-names></name>; <name><surname>Venkatasamy</surname><given-names>A.</given-names></name>; <name><surname>Yamamoto</surname><given-names>M.</given-names></name>; <name><surname>Nomura</surname><given-names>S.</given-names></name>; <name><surname>Tsukamoto</surname><given-names>T.</given-names></name>; <name><surname>Masson</surname><given-names>M.</given-names></name>; <name><surname>Gross</surname><given-names>I.</given-names></name>; <name><surname>Le Lagadec</surname><given-names>R.</given-names></name>; <name><surname>Mellitzer</surname><given-names>G.</given-names></name>; <name><surname>Gaiddon</surname><given-names>C.</given-names></name>
<article-title>The unfolded protein response-glutathione
metabolism axis: A novel target of a cycloruthenated complexes bypassing
tumor resistance mechanisms</article-title>. <source>Cancer Lett.</source>
<year>2024</year>, <volume>585</volume>, <elocation-id>216671</elocation-id><pub-id pub-id-type="doi">10.1016/j.canlet.2024.216671</pub-id>.<pub-id pub-id-type="pmid">38290658</pub-id>
</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Miyata</surname><given-names>K.</given-names></name>; <name><surname>Yasuda</surname><given-names>S.</given-names></name>; <name><surname>Masuya</surname><given-names>T.</given-names></name>; <name><surname>Ito</surname><given-names>S.</given-names></name>; <name><surname>Kinoshita</surname><given-names>Y.</given-names></name>; <name><surname>Tamiaki</surname><given-names>H.</given-names></name>; <name><surname>Oba</surname><given-names>T.</given-names></name>
<article-title>Facile iodination of
the vinyl groups
in protoporphyrin IX dimethyl ester and subsequent transformation
of the iodinated moieties</article-title>. <source>Tetrahedron</source>
<year>2018</year>, <volume>74</volume> (<issue>27</issue>), <fpage>3707</fpage>&#x02013;<lpage>3711</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2018.05.040</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Morgan</surname><given-names>A. R.</given-names></name>; <name><surname>Kohli</surname><given-names>D. H.</given-names></name>
<article-title>Diels-alder reactions of protoporphyrin IX dimethyl
ester</article-title>. <source>Tetrahedron Lett.</source>
<year>1995</year>, <volume>36</volume> (<issue>42</issue>), <fpage>7603</fpage>&#x02013;<lpage>7606</lpage>. <pub-id pub-id-type="doi">10.1016/0040-4039(95)01633-S</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>de
Oliveira</surname><given-names>K. T.</given-names></name>; <name><surname>Silva</surname><given-names>A. M. S.</given-names></name>; <name><surname>Tom&#x000e9;</surname><given-names>A. C.</given-names></name>; <name><surname>Neves</surname><given-names>M. G. P. M. S.</given-names></name>; <name><surname>Neri</surname><given-names>C. R.</given-names></name>; <name><surname>Garcia</surname><given-names>V. S.</given-names></name>; <name><surname>Serra</surname><given-names>O. A.</given-names></name>; <name><surname>Iamamoto</surname><given-names>Y.</given-names></name>; <name><surname>Cavaleiro</surname><given-names>J. A. S.</given-names></name>
<article-title>Synthesis of new amphiphilic chlorin
derivatives from protoporphyrin-IX dimethyl ester</article-title>. <source>Tetrahedron</source>
<year>2008</year>, <volume>64</volume> (<issue>37</issue>), <fpage>8709</fpage>&#x02013;<lpage>8715</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2008.06.103</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Rebou&#x000e7;as</surname><given-names>J. S.</given-names></name>; <name><surname>James</surname><given-names>B. R.</given-names></name>
<article-title>Ruthenium(II) complexes
of meso-tetrakis(4-cyanophenyl)porphyrin</article-title>. <source>Inorg.
Chem. Commun.</source>
<year>2013</year>, <volume>30</volume>, <fpage>49</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.inoche.2013.01.010</pub-id>.</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Chow</surname><given-names>B. C.</given-names></name>; <name><surname>Cohen</surname><given-names>I. A.</given-names></name>
<article-title>Derivatives of tetraphenylporphineruthenium (II)</article-title>. <source>Bioinorg. Chem.</source>
<year>1971</year>, <volume>1</volume> (<issue>1</issue>), <fpage>57</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3061(71)80001-7</pub-id>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Thandiayyakone</surname><given-names>V.</given-names></name>; <name><surname>Murugan</surname><given-names>A.</given-names></name>; <name><surname>Ravikumar</surname><given-names>C. R.</given-names></name>; <name><surname>Rajkumar</surname><given-names>T.</given-names></name>; <name><surname>Arasu</surname><given-names>P. T.</given-names></name>; <name><surname>Yadav</surname><given-names>H. S.</given-names></name>; <name><surname>Kotteeswaran</surname><given-names>P.</given-names></name>
<article-title>Studies on
redox and axial ligand
properties of Meso-Mn(III) porphyrin by cyclic voltammetry and UV&#x02013;Visible
spectrophotometry</article-title>. <source>Mater. Today: Proc.</source>
<year>2021</year>, <volume>47</volume>, <fpage>933</fpage>&#x02013;<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/j.matpr.2021.04.621</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Dar</surname><given-names>U. A.</given-names></name>; <name><surname>Shah</surname><given-names>S. A.</given-names></name>
<article-title>UV&#x02013;visible
and fluorescence spectroscopic assessment
of meso-tetrakis-(4-halophenyl) porphyrin; H2TXPP (X = F, Cl, Br,
I) in THF and THF-water system: Effect of pH and aggregation behaviour</article-title>. <source>Spectrochim. Acta, Part A</source>
<year>2020</year>, <volume>240</volume>, <elocation-id>118570</elocation-id><pub-id pub-id-type="doi">10.1016/j.saa.2020.118570</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Nas</surname><given-names>A.</given-names></name>; <name><surname>Fandakl&#x00131;</surname><given-names>S.</given-names></name>; <name><surname>Kantekin</surname><given-names>H.</given-names></name>; <name><surname>Demirba&#x0015f;</surname><given-names>A.</given-names></name>; <name><surname>Durmu&#x0015f;</surname><given-names>M.</given-names></name>
<article-title>Novel organosoluble
metal-free and metallophthalocyanines
bearing triazole moieties: Microwave assisted synthesis and determination
of photophysical and photochemical properties</article-title>. <source>Dyes Pigm.</source>
<year>2012</year>, <volume>95</volume> (<issue>1</issue>), <fpage>8</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.dyepig.2012.03.026</pub-id>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Linares</surname><given-names>I. A. P.</given-names></name>; <name><surname>de Oliveira</surname><given-names>K. T.</given-names></name>; <name><surname>Perussi</surname><given-names>J. R.</given-names></name>
<article-title>Chlorin derivatives
sterically-prevented from self-aggregation with high antitumor activity
for photodynamic therapy</article-title>. <source>Dyes Pigm.</source>
<year>2017</year>, <volume>145</volume>, <fpage>518</fpage>&#x02013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/j.dyepig.2017.06.011</pub-id>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Spiller</surname><given-names>W.</given-names></name>; <name><surname>Kliesch</surname><given-names>H.</given-names></name>; <name><surname>W&#x000f6;hrle</surname><given-names>D.</given-names></name>; <name><surname>Hackbarth</surname><given-names>S.</given-names></name>; <name><surname>R&#x000f6;der</surname><given-names>B.</given-names></name>; <name><surname>Schnurpfeil</surname><given-names>G.</given-names></name>
<article-title>Singlet oxygen
quantum yields of
different photosensitizers in polar solvents and micellar solutions</article-title>. <source>J. Porphyrins Phthalocyanines</source>
<year>1998</year>, <volume>2</volume> (<issue>2</issue>), <fpage>145</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1099-1409(199803/04)2:2&#x0003c;145::AID-JPP60&#x0003e;3.0.CO;2-2</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Pan</surname><given-names>J.</given-names></name>; <name><surname>Jiang</surname><given-names>L.</given-names></name>; <name><surname>Chan</surname><given-names>C.-F.</given-names></name>; <name><surname>Tsoi</surname><given-names>T.-H.</given-names></name>; <name><surname>Shiu</surname><given-names>K.-K.</given-names></name>; <name><surname>Kwong</surname><given-names>D. W. J.</given-names></name>; <name><surname>Wong</surname><given-names>W.-T.</given-names></name>; <name><surname>Wong</surname><given-names>W.-K.</given-names></name>; <name><surname>Wong</surname><given-names>K.-L.</given-names></name>
<article-title>Excitation
energy transfer in ruthenium (II)-porphyrin conjugates led to enhanced
emission quantum yield and <sup>1</sup>O<sub>2</sub> generation</article-title>. <source>J. Lumin.</source>
<year>2017</year>, <volume>184</volume>, <fpage>89</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.jlumin.2016.12.024</pub-id>.</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>McCarthy</surname><given-names>J. R.</given-names></name>; <name><surname>Weissleder</surname><given-names>R.</given-names></name>
<article-title>Model Systems for Fluorescence and
Singlet Oxygen Quenching
by Metalloporphyrins</article-title>. <source>ChemMedChem</source>
<year>2007</year>, <volume>2</volume> (<issue>3</issue>), <fpage>360</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.200600244</pub-id>.<pub-id pub-id-type="pmid">17245681</pub-id>
</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Mani</surname><given-names>A.</given-names></name>; <name><surname>Feng</surname><given-names>T.</given-names></name>; <name><surname>Gandioso</surname><given-names>A.</given-names></name>; <name><surname>Vinck</surname><given-names>R.</given-names></name>; <name><surname>Notaro</surname><given-names>A.</given-names></name>; <name><surname>Gourdon</surname><given-names>L.</given-names></name>; <name><surname>Burckel</surname><given-names>P.</given-names></name>; <name><surname>Saubam&#x000e9;a</surname><given-names>B.</given-names></name>; <name><surname>Blacque</surname><given-names>O.</given-names></name>; <name><surname>Cariou</surname><given-names>K.</given-names></name>; <name><surname>Belgaied</surname><given-names>J.-E.</given-names></name>; <name><surname>Chao</surname><given-names>H.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Structurally Simple Osmium(II) Polypyridyl
Complexes
as Photosensitizers for Photodynamic Therapy in the Near Infrared</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2023</year>, <volume>62</volume> (<issue>20</issue>), <elocation-id>e202218347</elocation-id><pub-id pub-id-type="doi">10.1002/anie.202218347</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Rovira</surname><given-names>A.</given-names></name>; <name><surname>Ortega-Forte</surname><given-names>E.</given-names></name>; <name><surname>Hally</surname><given-names>C.</given-names></name>; <name><surname>Jord&#x000e0;-Redondo</surname><given-names>M.</given-names></name>; <name><surname>Abad-Montero</surname><given-names>D.</given-names></name>; <name><surname>Vigueras</surname><given-names>G.</given-names></name>; <name><surname>Mart&#x000ed;nez</surname><given-names>J. I.</given-names></name>; <name><surname>Bosch</surname><given-names>M.</given-names></name>; <name><surname>Nonell</surname><given-names>S.</given-names></name>; <name><surname>Ruiz</surname><given-names>J.</given-names></name>; <name><surname>March&#x000e1;n</surname><given-names>V.</given-names></name>
<article-title>Exploring
Structure&#x02013;Activity Relationships in Photodynamic Therapy Anticancer
Agents Based on Ir(III)-COUPY Conjugates</article-title>. <source>J.
Med. Chem.</source>
<year>2023</year>, <volume>66</volume> (<issue>12</issue>), <fpage>7849</fpage>&#x02013;<lpage>7867</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.3c00189</pub-id>.<pub-id pub-id-type="pmid">37265008</pub-id>
</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Buettner</surname><given-names>G. R.</given-names></name>
<article-title>Spin Trapping:
ESR parameters of spin adducts 1474 1528V</article-title>. <source>Free
Radical Biol. Med.</source>
<year>1987</year>, <volume>3</volume> (<issue>4</issue>), <fpage>259</fpage>&#x02013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(87)80033-3</pub-id>.<pub-id pub-id-type="pmid">2826304</pub-id>
</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Brahmi</surname><given-names>J.</given-names></name>; <name><surname>Nasri</surname><given-names>S.</given-names></name>; <name><surname>Saidi</surname><given-names>H.</given-names></name>; <name><surname>Nasri</surname><given-names>H.</given-names></name>; <name><surname>Aouadi</surname><given-names>K.</given-names></name>
<article-title>Synthesis
of New Porphyrin Complexes: Evaluations on Optical, Electrochemical,
Electronic Properties and Application as an Optical Sensor</article-title>. <source>ChemistrySelect</source>
<year>2019</year>, <volume>4</volume> (<issue>4</issue>), <fpage>1350</fpage>&#x02013;<lpage>1359</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201803676</pub-id>.</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Xu</surname><given-names>S.</given-names></name>; <name><surname>Yuan</surname><given-names>Y.</given-names></name>; <name><surname>Cai</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>C.-J.</given-names></name>; <name><surname>Hu</surname><given-names>F.</given-names></name>; <name><surname>Liang</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>G.</given-names></name>; <name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Liu</surname><given-names>B.</given-names></name>
<article-title>Tuning the
singlet-triplet energy gap: a unique approach to efficient photosensitizers
with aggregation-induced emission (AIE) characteristics</article-title>. <source>Chem. Sci.</source>
<year>2015</year>, <volume>6</volume> (<issue>10</issue>), <fpage>5824</fpage>&#x02013;<lpage>5830</lpage>. <pub-id pub-id-type="doi">10.1039/C5SC01733E</pub-id>.<pub-id pub-id-type="pmid">28791088</pub-id>
</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Fukuzumi</surname><given-names>S.</given-names></name>; <name><surname>Ohkubo</surname><given-names>K.</given-names></name>; <name><surname>Zheng</surname><given-names>X.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Pandey</surname><given-names>R. K.</given-names></name>; <name><surname>Zhan</surname><given-names>R.</given-names></name>; <name><surname>Kadish</surname><given-names>K. M.</given-names></name>
<article-title>Metal Bacteriochlorins
Which Act
as Dual Singlet Oxygen and Superoxide Generators</article-title>. <source>J. Phys. Chem. B</source>
<year>2008</year>, <volume>112</volume> (<issue>9</issue>), <fpage>2738</fpage>&#x02013;<lpage>2746</lpage>. <pub-id pub-id-type="doi">10.1021/jp0766757</pub-id>.<pub-id pub-id-type="pmid">18254618</pub-id>
</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Daina</surname><given-names>A.</given-names></name>; <name><surname>Michielin</surname><given-names>O.</given-names></name>; <name><surname>Zoete</surname><given-names>V.</given-names></name>
<article-title>iLOGP: A Simple, Robust, and Efficient
Description of n-Octanol/Water Partition Coefficient for Drug Design
Using the GB/SA Approach</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2014</year>, <volume>54</volume> (<issue>12</issue>), <fpage>3284</fpage>&#x02013;<lpage>3301</lpage>. <pub-id pub-id-type="doi">10.1021/ci500467k</pub-id>.<pub-id pub-id-type="pmid">25382374</pub-id>
</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Stephan</surname><given-names>K.</given-names></name>; <name><surname>Saab</surname><given-names>J.</given-names></name>; <name><surname>Mokbel</surname><given-names>I.</given-names></name>; <name><surname>Goutaudier</surname><given-names>C.</given-names></name>; <name><surname>Ferrigno</surname><given-names>R.</given-names></name>
<article-title>Continuous-flow microfluidic method
for octanol-water
partition coefficient measurement</article-title>. <source>Fluid Phase
Equilib.</source>
<year>2014</year>, <volume>380</volume>, <fpage>116</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.fluid.2014.07.033</pub-id>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Kim</surname><given-names>K.</given-names></name>; <name><surname>Park</surname><given-names>H.</given-names></name>; <name><surname>Lim</surname><given-names>K.-M.</given-names></name>
<article-title>Phototoxicity: Its Mechanism and
Animal Alternative Test Methods</article-title>. <source>Toxicol. Res.</source>
<year>2015</year>, <volume>31</volume> (<issue>2</issue>), <fpage>97</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.5487/TR.2015.31.2.097</pub-id>.<pub-id pub-id-type="pmid">26191378</pub-id>
</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Heinemann</surname><given-names>F.</given-names></name>; <name><surname>Karges</surname><given-names>J.</given-names></name>; <name><surname>Gasser</surname><given-names>G.</given-names></name>
<article-title>Critical Overview of the Use of Ru(II)
Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon
Photodynamic Therapy</article-title>. <source>Acc. Chem. Res.</source>
<year>2017</year>, <volume>50</volume> (<issue>11</issue>), <fpage>2727</fpage>&#x02013;<lpage>2736</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00180</pub-id>.<pub-id pub-id-type="pmid">29058879</pub-id>
</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>; <name><surname>Xie</surname><given-names>M.</given-names></name>; <name><surname>Guo</surname><given-names>S.</given-names></name>; <name><surname>Zhao</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Zhao</surname><given-names>Q.</given-names></name>
<article-title>Rational design of type I photosensitizers based on
Ru(II) complexes for effective photodynamic therapy under hypoxia</article-title>. <source>Dalton Trans.</source>
<year>2020</year>, <volume>49</volume> (<issue>32</issue>), <fpage>11192</fpage>&#x02013;<lpage>11200</lpage>. <pub-id pub-id-type="doi">10.1039/D0DT01684E</pub-id>.<pub-id pub-id-type="pmid">32748922</pub-id>
</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Mishchenko</surname><given-names>T.</given-names></name>; <name><surname>Balalaeva</surname><given-names>I.</given-names></name>; <name><surname>Gorokhova</surname><given-names>A.</given-names></name>; <name><surname>Vedunova</surname><given-names>M.</given-names></name>; <name><surname>Krysko</surname><given-names>D. V.</given-names></name>
<article-title>Which cell
death modality wins the contest for photodynamic therapy of cancer?</article-title>. <source>Cell Death Dis.</source>
<year>2022</year>, <volume>13</volume> (<issue>5</issue>), <elocation-id>455</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-022-04851-4</pub-id>.<pub-id pub-id-type="pmid">35562364</pub-id>
</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Ha</surname><given-names>J.-H.</given-names></name>; <name><surname>Kim</surname><given-names>Y.-J.</given-names></name>
<article-title>Photodynamic and
Cold Atmospheric Plasma Combination
Therapy Using Polymeric Nanoparticles for the Synergistic Treatment
of Cervical Cancer</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2021</year>, <volume>22</volume> (<issue>3</issue>), <elocation-id>1172</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22031172</pub-id>.<pub-id pub-id-type="pmid">33504007</pub-id>
</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Brabec</surname><given-names>V.</given-names></name>; <name><surname>Kasparkova</surname><given-names>J.</given-names></name>
<article-title>Ruthenium coordination compounds of biological and
biomedical significance. DNA binding agents</article-title>. <source>Coord. Chem. Rev.</source>
<year>2018</year>, <volume>376</volume>, <fpage>75</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2018.07.012</pub-id>.</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Sudhindra</surname><given-names>P.</given-names></name>; <name><surname>Sharma</surname><given-names>S. A.</given-names></name>; <name><surname>Roy</surname><given-names>N.</given-names></name>; <name><surname>Moharana</surname><given-names>P.</given-names></name>; <name><surname>Paira</surname><given-names>P.</given-names></name>
<article-title>Recent advances
in cytotoxicity, cellular uptake and mechanism of action of ruthenium
metallodrugs: A review</article-title>. <source>Polyhedron</source>
<year>2020</year>, <volume>192</volume>, <elocation-id>114827</elocation-id><pub-id pub-id-type="doi">10.1016/j.poly.2020.114827</pub-id>.</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Dorairaj</surname><given-names>D. P.</given-names></name>; <name><surname>Haribabu</surname><given-names>J.</given-names></name>; <name><surname>Dharmasivam</surname><given-names>M.</given-names></name>; <name><surname>Malekshah</surname><given-names>R. E.</given-names></name>; <name><surname>Subarkhan</surname><given-names>M. K. M.</given-names></name>; <name><surname>Echeverria</surname><given-names>C.</given-names></name>; <name><surname>Karvembu</surname><given-names>R.</given-names></name>
<article-title>Ru(II)-p-Cymene Complexes
of Furoylthiourea Ligands for Anticancer Applications against Breast
Cancer Cells</article-title>. <source>Inorg. Chem.</source>
<year>2023</year>, <volume>62</volume> (<issue>30</issue>), <fpage>11761</fpage>&#x02013;<lpage>11774</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c00757</pub-id>.<pub-id pub-id-type="pmid">37459067</pub-id>
</mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Zhou</surname><given-names>Q.</given-names></name>; <name><surname>Deng</surname><given-names>Z.</given-names></name>; <name><surname>Tong</surname><given-names>Z.</given-names></name>; <name><surname>Tse</surname><given-names>M.-K.</given-names></name>; <name><surname>Zhu</surname><given-names>G.</given-names></name>
<article-title>Synthesis,
Cytotoxicity, and Mechanistic Investigation of Platinum(IV)
Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors</article-title>. <source>Inorg. Chem.</source>
<year>2019</year>, <volume>58</volume> (<issue>23</issue>), <fpage>16279</fpage>&#x02013;<lpage>16291</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.9b02839</pub-id>.<pub-id pub-id-type="pmid">31738050</pub-id>
</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Mao</surname><given-names>J.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Jiang</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Tan</surname><given-names>G.</given-names></name>; <name><surname>Xie</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Sun</surname><given-names>J.</given-names></name>
<article-title>Reducing PKC&#x003b4;
inhibits tumor growth through growth hormone
by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma</article-title>. <source>Sci. Rep.</source>
<year>2025</year>, <volume>15</volume> (<issue>1</issue>), <elocation-id>11461</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-025-95865-3</pub-id>.<pub-id pub-id-type="pmid">40181069</pub-id>
</mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Devarajan</surname><given-names>E.</given-names></name>; <name><surname>Sahin</surname><given-names>A. A.</given-names></name>; <name><surname>Chen</surname><given-names>J. S.</given-names></name>; <name><surname>Krishnamurthy</surname><given-names>R. R.</given-names></name>; <name><surname>Aggarwal</surname><given-names>N.</given-names></name>; <name><surname>Brun</surname><given-names>A.-M.</given-names></name>; <name><surname>Sapino</surname><given-names>A.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Sharma</surname><given-names>D.</given-names></name>; <name><surname>Yang</surname><given-names>X.-H.</given-names></name>; <name><surname>Tora</surname><given-names>A. D.</given-names></name>; <name><surname>Mehta</surname><given-names>K.</given-names></name>
<article-title>Down-regulation
of caspase 3 in breast cancer: a possible mechanism for chemoresistance</article-title>. <source>Oncogene</source>
<year>2002</year>, <volume>21</volume> (<issue>57</issue>), <fpage>8843</fpage>&#x02013;<lpage>8851</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206044</pub-id>.<pub-id pub-id-type="pmid">12483536</pub-id>
</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Ding</surname><given-names>M.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Fang</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Shan</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>L.</given-names></name>; <name><surname>Sun</surname><given-names>H.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>X.</given-names></name>; <name><surname>Zhu</surname><given-names>L.</given-names></name>; <name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Assaraf</surname><given-names>Y. G.</given-names></name>; <name><surname>Zhou</surname><given-names>B.-B. S.</given-names></name>; <name><surname>Gu</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>
<article-title>Therapeutic
targeting de novo purine biosynthesis driven by &#x003b2;-catenin-dependent
PPAT upregulation in hepatoblastoma</article-title>. <source>Cell Death
Dis.</source>
<year>2025</year>, <volume>16</volume> (<issue>1</issue>), <elocation-id>179</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-025-07502-6</pub-id>.<pub-id pub-id-type="pmid">40097378</pub-id>
</mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Pan</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Wright</surname><given-names>W. C.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Passaia</surname><given-names>B.</given-names></name>; <name><surname>Currier</surname><given-names>D.</given-names></name>; <name><surname>Low</surname><given-names>J.</given-names></name>; <name><surname>Chapple</surname><given-names>R. H.</given-names></name>; <name><surname>Steele</surname><given-names>J. A.</given-names></name>; <name><surname>Connelly</surname><given-names>J. P.</given-names></name>; <name><surname>Ju</surname><given-names>B.</given-names></name>; <name><surname>Plyler</surname><given-names>E.</given-names></name>; <name><surname>Lu</surname><given-names>M.</given-names></name>; <name><surname>Loughran</surname><given-names>A. J.</given-names></name>; <name><surname>Yang</surname><given-names>L.</given-names></name>; <name><surname>Abraham</surname><given-names>B. J.</given-names></name>; <name><surname>Pruett-Miller</surname><given-names>S. M.</given-names></name>; <name><surname>Freeman</surname><given-names>B.</given-names></name>; <name><surname>Campbell</surname><given-names>G. E.</given-names></name>; <name><surname>Dyer</surname><given-names>M. A.</given-names></name>; <name><surname>Chen</surname><given-names>T.</given-names></name>; <name><surname>Stewart</surname><given-names>E.</given-names></name>; <name><surname>Koo</surname><given-names>S.</given-names></name>; <name><surname>Sheppard</surname><given-names>H.</given-names></name>; et al. <article-title>Bone morphogenetic
protein (BMP) signaling determines neuroblastoma cell fate and sensitivity
to retinoic acid</article-title>. <source>Nat. Commun.</source>
<year>2025</year>, <volume>16</volume> (<issue>1</issue>), <elocation-id>2036</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-025-57185-y</pub-id>.<pub-id pub-id-type="pmid">40021625</pub-id>
</mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Fang</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>
<article-title>Berberine-photodynamic
induced apoptosis by activating endoplasmic
reticulum stress-autophagy pathway involving CHOP in human malignant
melanoma cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<year>2021</year>, <volume>552</volume>, <fpage>183</fpage>&#x02013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2021.02.147</pub-id>.<pub-id pub-id-type="pmid">33751936</pub-id>
</mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Lee</surname><given-names>Y.-S.</given-names></name>; <name><surname>Lee</surname><given-names>D.-H.</given-names></name>; <name><surname>Choudry</surname><given-names>H. A.</given-names></name>; <name><surname>Bartlett</surname><given-names>D. L.</given-names></name>; <name><surname>Lee</surname><given-names>Y. J.</given-names></name>
<article-title>Ferroptosis-Induced
Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis</article-title>. <source>Mol. Cancer Res.</source>
<year>2018</year>, <volume>16</volume> (<issue>7</issue>), <fpage>1073</fpage>&#x02013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-18-0055</pub-id>.<pub-id pub-id-type="pmid">29592897</pub-id>
</mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Ochoa</surname><given-names>C. D.</given-names></name>; <name><surname>Wu</surname><given-names>R. F.</given-names></name>; <name><surname>Terada</surname><given-names>L. S.</given-names></name>
<article-title>ROS signaling
and ER stress in cardiovascular
disease</article-title>. <source>Mol. Aspects Med.</source>
<year>2018</year>, <volume>63</volume>, <fpage>18</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2018.03.002</pub-id>.<pub-id pub-id-type="pmid">29559224</pub-id>
</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Zhao</surname><given-names>T.</given-names></name>; <name><surname>Wu</surname><given-names>K.</given-names></name>; <name><surname>Hogstrand</surname><given-names>C.</given-names></name>; <name><surname>Xu</surname><given-names>Y.-H.</given-names></name>; <name><surname>Chen</surname><given-names>G.-H.</given-names></name>; <name><surname>Wei</surname><given-names>C.-C.</given-names></name>; <name><surname>Luo</surname><given-names>Z.</given-names></name>
<article-title>Lipophagy
mediated carbohydrate-induced changes of lipid metabolism
via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPAR&#x003b3;
pathways</article-title>. <source>Cell. Mol. Life Sci.</source>
<year>2020</year>, <volume>77</volume> (<issue>10</issue>), <fpage>1987</fpage>&#x02013;<lpage>2003</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-019-03263-6</pub-id>.<pub-id pub-id-type="pmid">31392349</pub-id>
</mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Verfaillie</surname><given-names>T.</given-names></name>; <name><surname>Salazar</surname><given-names>M.</given-names></name>; <name><surname>Velasco</surname><given-names>G.</given-names></name>; <name><surname>Agostinis</surname><given-names>P.</given-names></name>
<article-title>Linking ER
Stress to Autophagy: Potential Implications for Cancer Therapy</article-title>. <source>Int. J. Cell Biol.</source>
<year>2010</year>, <volume>2010</volume> (<issue>1</issue>), <elocation-id>930509</elocation-id><pub-id pub-id-type="doi">10.1155/2010/930509</pub-id>.<pub-id pub-id-type="pmid">20145727</pub-id>
</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>Song</surname><given-names>S.</given-names></name>; <name><surname>Tan</surname><given-names>J.</given-names></name>; <name><surname>Miao</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>
<article-title>Crosstalk of autophagy
and apoptosis: Involvement of the dual role of autophagy under ER
stress</article-title>. <source>J. Cell. Physiol.</source>
<year>2017</year>, <volume>232</volume> (<issue>11</issue>), <fpage>2977</fpage>&#x02013;<lpage>2984</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.25785</pub-id>.<pub-id pub-id-type="pmid">28067409</pub-id>
</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name><surname>Kania</surname><given-names>E.</given-names></name>; <name><surname>Paj&#x00105;k</surname><given-names>B.</given-names></name>; <name><surname>Orzechowski</surname><given-names>A.</given-names></name>
<article-title>Calcium Homeostasis and ER Stress
in Control of Autophagy in Cancer Cells</article-title>. <source>BioMed
Res. Int.</source>
<year>2015</year>, <volume>2015</volume> (<issue>1</issue>), <elocation-id>352794</elocation-id><pub-id pub-id-type="doi">10.1155/2015/352794</pub-id>.<pub-id pub-id-type="pmid">25821797</pub-id>
</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Luo</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Han</surname><given-names>D.</given-names></name>; <name><surname>Yang</surname><given-names>K.</given-names></name>; <name><surname>Kang</surname><given-names>L.</given-names></name>
<article-title>Inhibition of autophagy
enhances apoptosis induced by Ce6-photodynamic therapy in human colon
cancer cells</article-title>. <source>Photodiagn. Photodyn. Ther.</source>
<year>2021</year>, <volume>36</volume>, <elocation-id>102605</elocation-id><pub-id pub-id-type="doi">10.1016/j.pdpdt.2021.102605</pub-id>.</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>Rouschop</surname><given-names>K.</given-names></name>; <name><surname>Bradly</surname><given-names>G. W.</given-names></name>
<article-title>Regulation of Autophagy
Through Multiple Independent
Hypoxic Signaling Pathways</article-title>. <source>Curr. Mol. Med.</source>
<year>2009</year>, <volume>9</volume> (<issue>4</issue>), <fpage>417</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.2174/156652409788167131</pub-id>.<pub-id pub-id-type="pmid">19519399</pub-id>
</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name><surname>Ouyang</surname><given-names>G.</given-names></name>; <name><surname>Xiong</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Lam</surname><given-names>B.</given-names></name>; <name><surname>Bui</surname><given-names>B.</given-names></name>; <name><surname>Ma</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Zhou</surname><given-names>P.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Miao</surname><given-names>X.</given-names></name>; <name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Wen</surname><given-names>Y.</given-names></name>
<article-title>Inhibition
of autophagy potentiates the apoptosis-inducing effects of photodynamic
therapy on human colon cancer cells</article-title>. <source>Photodiagn.
Photodyn. Ther.</source>
<year>2018</year>, <volume>21</volume>, <fpage>396</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1016/j.pdpdt.2018.01.010</pub-id>.</mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>P.</given-names></name>; <name><surname>Zhai</surname><given-names>B.</given-names></name>; <name><surname>Zhang</surname><given-names>M.</given-names></name>; <name><surname>Xiang</surname><given-names>Y.</given-names></name>; <name><surname>Fang</surname><given-names>J.</given-names></name>; <name><surname>Xu</surname><given-names>S.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Sui</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<article-title>The emerging role of ferroptosis in inflammation</article-title>. <source>Biomed. Pharmacother.</source>
<year>2020</year>, <volume>127</volume>, <elocation-id>110108</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110108</pub-id>.<pub-id pub-id-type="pmid">32234642</pub-id>
</mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>Kajarabille</surname><given-names>N.</given-names></name>; <name><surname>Latunde-Dada</surname><given-names>G. O.</given-names></name>
<article-title>Programmed Cell-Death by Ferroptosis:
Antioxidants
as Mitigators</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2019</year>, <volume>20</volume> (<issue>19</issue>), <elocation-id>4968</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20194968</pub-id>.<pub-id pub-id-type="pmid">31597407</pub-id>
</mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name><surname>Friedmann
Angeli</surname><given-names>J. P.</given-names></name>; <name><surname>Krysko</surname><given-names>D. V.</given-names></name>; <name><surname>Conrad</surname><given-names>M.</given-names></name>
<article-title>Ferroptosis at the
crossroads of cancer-acquired drug resistance and immune evasion</article-title>. <source>Nat. Rev. Cancer</source>
<year>2019</year>, <volume>19</volume> (<issue>7</issue>), <fpage>405</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1038/s41568-019-0149-1</pub-id>.<pub-id pub-id-type="pmid">31101865</pub-id>
</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Gurram</surname><given-names>B.</given-names></name>; <name><surname>Zhang</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Xie</surname><given-names>Y.</given-names></name>; <name><surname>Cui</surname><given-names>H.</given-names></name>; <name><surname>Du</surname><given-names>J.</given-names></name>; <name><surname>Fan</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Peng</surname><given-names>X.</given-names></name>
<article-title>Celecoxib
Conjugated Fluorescent Probe for Identification and Discrimination
of Cyclooxygenase-2 Enzyme in Cancer Cells</article-title>. <source>Anal. Chem.</source>
<year>2018</year>, <volume>90</volume> (<issue>8</issue>), <fpage>5187</fpage>&#x02013;<lpage>5193</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.7b05337</pub-id>.<pub-id pub-id-type="pmid">29587478</pub-id>
</mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Hashemi
Goradel</surname><given-names>N.</given-names></name>; <name><surname>Najafi</surname><given-names>M.</given-names></name>; <name><surname>Salehi</surname><given-names>E.</given-names></name>; <name><surname>Farhood</surname><given-names>B.</given-names></name>; <name><surname>Mortezaee</surname><given-names>K.</given-names></name>
<article-title>Cyclooxygenase-2 in cancer: A review</article-title>. <source>J. Cell. Physiol.</source>
<year>2019</year>, <volume>234</volume> (<issue>5</issue>), <fpage>5683</fpage>&#x02013;<lpage>5699</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27411</pub-id>.<pub-id pub-id-type="pmid">30341914</pub-id>
</mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name><surname>Faur&#x000e9;</surname><given-names>M.</given-names></name>; <name><surname>Saccavini</surname><given-names>C.</given-names></name>; <name><surname>Lavigne</surname><given-names>G.</given-names></name>
<article-title>New insight into a convenient base-promoted
synthesis of Ru<sub>3</sub>(CO)<sub>12</sub></article-title>. <source>Chem. Commun.</source>
<year>2003</year>, (<issue>13</issue>), <fpage>1578</fpage>&#x02013;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1039/B303884J</pub-id>.</mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="computer-program" id="cit87"><source>SAINT</source>; <publisher-name>Bruker AXS Inc.</publisher-name>: <publisher-loc>Madison, Wisconsin, USA</publisher-loc>, <year>2012</year>.</mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="computer-program" id="cit88"><source>APEX2</source>; <publisher-name>Bruker AXS Inc.</publisher-name>: <publisher-loc>Madison, Wisconsin, USA</publisher-loc>, <year>2012</year>.</mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name><surname>de
Assis</surname><given-names>F. F.</given-names></name>; <name><surname>de Souza</surname><given-names>J. M.</given-names></name>; <name><surname>Assis</surname><given-names>B. H. K.</given-names></name>; <name><surname>Brocksom</surname><given-names>T. J.</given-names></name>; <name><surname>de Oliveira</surname><given-names>K. T.</given-names></name>
<article-title>Synthesis and photophysical studies of a chlorin sterically
designed to prevent self-aggregation</article-title>. <source>Dyes Pigm.</source>
<year>2013</year>, <volume>98</volume> (<issue>1</issue>), <fpage>153</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.dyepig.2013.02.011</pub-id>.</mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name><surname>Siahcheshm</surname><given-names>P.</given-names></name>; <name><surname>Heiden</surname><given-names>P.</given-names></name>
<article-title>High quantum yield carbon quantum dots as selective
fluorescent turn-off probes for dual detection of Fe<sup>2+</sup>/Fe<sup>3+</sup> ions</article-title>. <source>J. Photochem. Photobiol., A</source>
<year>2023</year>, <volume>435</volume>, <elocation-id>114284</elocation-id><pub-id pub-id-type="doi">10.1016/j.jphotochem.2022.114284</pub-id>.</mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Shang</surname><given-names>X.</given-names></name>; <name><surname>Chao</surname><given-names>D.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>
<article-title>Highly sensitive
and selective detection of Fe<sup>3+</sup> by utilizing carbon quantum
dots as fluorescent probes</article-title>. <source>Chem. Phys. Lett.</source>
<year>2018</year>, <volume>705</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cplett.2018.05.048</pub-id>.</mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name><surname>Seotsanyana-Mokhosi</surname><given-names>I.</given-names></name>; <name><surname>Kuznetsova</surname><given-names>N.</given-names></name>; <name><surname>Nyokong</surname><given-names>T.</given-names></name>
<article-title>Photochemical studies of tetra-2,3-pyridinoporphyrazines</article-title>. <source>J. Photochem. Photobiol., A</source>
<year>2001</year>, <volume>140</volume> (<issue>3</issue>), <fpage>215</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/S1010-6030(01)00427-0</pub-id>.</mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name><surname>Swavey</surname><given-names>S.</given-names></name>; <name><surname>Quentel</surname><given-names>A.</given-names></name>; <name><surname>Grzesiak</surname><given-names>M.</given-names></name>; <name><surname>Hawkins</surname><given-names>C.</given-names></name>; <name><surname>Vidi</surname><given-names>P.-A.</given-names></name>
<article-title>Efficient
light-induced reactive oxygen species production from a far-red ER-targeting
BODIPY dye</article-title>. <source>RSC Adv.</source>
<year>2024</year>, <volume>14</volume> (<issue>52</issue>), <fpage>38796</fpage>&#x02013;<lpage>38805</lpage>. <pub-id pub-id-type="doi">10.1039/D4RA05603E</pub-id>.<pub-id pub-id-type="pmid">39654916</pub-id>
</mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name><surname>Benson</surname><given-names>S.</given-names></name>; <name><surname>de Moliner</surname><given-names>F.</given-names></name>; <name><surname>Fernandez</surname><given-names>A.</given-names></name>; <name><surname>Kuru</surname><given-names>E.</given-names></name>; <name><surname>Asiimwe</surname><given-names>N. L.</given-names></name>; <name><surname>Lee</surname><given-names>J.-S.</given-names></name>; <name><surname>Hamilton</surname><given-names>L.</given-names></name>; <name><surname>Sieger</surname><given-names>D.</given-names></name>; <name><surname>Bravo</surname><given-names>I. R.</given-names></name>; <name><surname>Elliot</surname><given-names>A. M.</given-names></name>; <name><surname>Feng</surname><given-names>Y.</given-names></name>; <name><surname>Vendrell</surname><given-names>M.</given-names></name>
<article-title>Photoactivatable metabolic
warheads enable precise and safe ablation of target cells in vivo</article-title>. <source>Nat. Commun.</source>
<year>2021</year>, <volume>12</volume> (<issue>1</issue>), <elocation-id>2369</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22578-2</pub-id>.<pub-id pub-id-type="pmid">33888691</pub-id>
</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name><surname>Nardi</surname><given-names>G.</given-names></name>; <name><surname>Manet</surname><given-names>I.</given-names></name>; <name><surname>Monti</surname><given-names>S.</given-names></name>; <name><surname>Miranda</surname><given-names>M. A.</given-names></name>; <name><surname>Lhiaubet-Vallet</surname><given-names>V.</given-names></name>
<article-title>Scope and
limitations of the TEMPO/EPR method for singlet oxygen detection:
the misleading role of electron transfer</article-title>. <source>Free
Radical Biol. Med.</source>
<year>2014</year>, <volume>77</volume>, <fpage>64</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.08.020</pub-id>.<pub-id pub-id-type="pmid">25236741</pub-id>
</mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name><surname>Andr&#x000e9;s</surname><given-names>A.</given-names></name>; <name><surname>Ros&#x000e9;s</surname><given-names>M.</given-names></name>; <name><surname>R&#x000e0;fols</surname><given-names>C.</given-names></name>; <name><surname>Bosch</surname><given-names>E.</given-names></name>; <name><surname>Espinosa</surname><given-names>S.</given-names></name>; <name><surname>Segarra</surname><given-names>V.</given-names></name>; <name><surname>Huerta</surname><given-names>J. M.</given-names></name>
<article-title>Setup and validation of shake-flask
procedures for the determination of partition coefficients (logD)
from low drug amounts</article-title>. <source>Eur. J. Pharm. Sci.</source>
<year>2015</year>, <volume>76</volume>, <fpage>181</fpage>&#x02013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2015.05.008</pub-id>.<pub-id pub-id-type="pmid">25968358</pub-id>
</mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name><surname>Ballester</surname><given-names>F. J.</given-names></name>; <name><surname>Ortega</surname><given-names>E.</given-names></name>; <name><surname>Bautista</surname><given-names>D.</given-names></name>; <name><surname>Santana</surname><given-names>M. D.</given-names></name>; <name><surname>Ruiz</surname><given-names>J.</given-names></name>
<article-title>Ru(II) photosensitizers
competent for hypoxic cancers via green light activation</article-title>. <source>Chem. Commun.</source>
<year>2020</year>, <volume>56</volume> (<issue>71</issue>), <fpage>10301</fpage>&#x02013;<lpage>10304</lpage>. <pub-id pub-id-type="doi">10.1039/D0CC02417A</pub-id>.</mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Du</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Bai</surname><given-names>J.</given-names></name>; <name><surname>Cui</surname><given-names>G.</given-names></name>; <name><surname>Du</surname><given-names>Z.</given-names></name>
<article-title>Involvement of the JNK/HO-1/FTH1
signaling pathway in nanoplastic-induced inflammation and ferroptosis
of BV2 microglia cells</article-title>. <source>Int. J. Mol. Med.</source>
<year>2023</year>, <volume>52</volume> (<issue>1</issue>), <elocation-id>61</elocation-id><pub-id pub-id-type="doi">10.3892/ijmm.2023.5264</pub-id>.<pub-id pub-id-type="pmid">37264973</pub-id>
</mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name><surname>Schneider</surname><given-names>C. A.</given-names></name>; <name><surname>Rasband</surname><given-names>W. S.</given-names></name>; <name><surname>Eliceiri</surname><given-names>K. W.</given-names></name>
<article-title>NIH Image to ImageJ: 25 years of
image analysis</article-title>. <source>Nat. Methods</source>
<year>2012</year>, <volume>9</volume> (<issue>7</issue>), <fpage>671</fpage>&#x02013;<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id>.<pub-id pub-id-type="pmid">22930834</pub-id>
</mixed-citation></ref></ref-list></back></article>